TSS:Rfhg 54364.1

Basic information about the TSS

---

TSS ID: rfhg_54364.1 Species: human Chr: chr3		Start: 191329265 End: 191329300 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3532358,EH38E2269294)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000392455.9:94 GeneID: 152137 HGNC/MGI_ID: HGNC:18111 UniProt_ID: Q8IVM0 Nearer transcript ids and distances: ENST00000392456.4:-180 AJ416916:-180 AJ557013:-180 BC065004:288 CU687992:372 KJ895670:372 HQ448050:372 view more...

Gene_name: coiled-coil domain containing 50 Gene_symbol: CCDC50 Gene_synonyms: Ymer Gene_source: HGNC:18111

TATA-Box annotation

---

Distance to TSS:	-112
Nearest PromoterID:	NM_174908
Entrez ID:	152137
Nearest Unigene:	Hs.478682
Nearest Refseq:	NM_174908
Nearest Ensembl:	ENSG00000152492
Gene Name:	coiled-coil domain containing 50
Gene Alias:	C3orf6|DFNA44|YMER
Gene Type:	protein-coding
CpG%:	0.142857
GC%:	0.722222
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCDC50 p2@CCDC50 p3@CCDC50 p4@CCDC50 p5@CCDC50 p6@CCDC50 p7@CCDC50 p8@CCDC50 p9@CCDC50
Sample		p1@CCDC50	p2@CCDC50	p3@CCDC50	p4@CCDC50	p5@CCDC50	p6@CCDC50	p7@CCDC50	p8@CCDC50	p9@CCDC50
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.00	4.09	9.16	10.91	0.19	0.97	0.78	0.00	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	18.01	3.64	9.31	13.35	0.40	0.81	1.62	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.17	3.47	9.65	11.00	0.39	0.58	1.54	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.42	3.12	6.86	9.15	0.00	0.83	1.25	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.40	2.70	4.95	9.90	0.22	0.22	2.02	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.92	4.07	8.33	9.30	0.19	0.97	0.97	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.39	4.14	8.06	10.46	0.87	0.22	0.87	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.53	4.84	7.75	8.24	1.21	0.73	1.21	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.94	5.77	7.05	6.84	0.00	0.64	1.50	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.87	4.64	6.38	8.69	0.58	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.64	5.26	5.66	6.87	0.00	0.81	2.02	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.33	4.88	7.72	7.72	0.81	1.63	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	43.36	6.45	4.19	2.90	1.77	0.81	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	35.03	4.36	2.56	2.10	1.20	0.90	1.05	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.50	4.61	2.20	2.42	1.10	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.47	5.28	4.02	1.26	1.01	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	29.05	4.15	3.93	1.97	0.44	1.09	0.87	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.01	5.06	3.80	2.95	1.27	1.27	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	2.13	2.67	2.67	1.07	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.92	4.96	2.86	2.26	1.81	0.60	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.10	6.28	4.54	3.74	1.34	0.94	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.15	5.18	3.80	3.28	0.86	1.21	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.76	5.56	1.81	2.97	2.07	0.65	0.26	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.89	4.85	2.18	2.18	1.21	0.97	0.97	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.99	4.64	4.13	2.58	2.32	1.03	0.26	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.35	5.70	3.17	3.17	1.58	0.63	0.63	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.77	4.40	2.20	3.85	2.75	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	38.19	6.84	4.95	4.48	1.41	0.71	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.50	3.55	2.91	1.94	0.81	0.81	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	39.27	4.34	3.44	3.26	1.81	0.54	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	37.05	6.49	4.19	4.61	2.51	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	40.05	4.88	3.91	1.37	1.95	0.39	1.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	39.46	6.33	4.22	4.64	1.69	1.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	33.32	3.13	4.12	2.97	1.48	1.81	0.66	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	38.15	4.86	4.86	4.11	2.43	1.12	0.93	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.01	5.17	3.07	4.41	1.72	1.15	0.77	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	43.94	6.74	4.91	3.68	1.64	1.23	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.26	3.43	2.01	3.43	2.22	1.01	0.40	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.33	6.48	5.13	4.59	1.08	1.89	0.54	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	40.57	6.24	4.32	4.32	1.20	1.20	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.99	4.23	3.53	5.65	3.53	1.41	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	34.55	5.42	5.27	6.00	1.17	1.76	0.73	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	43.87	5.48	3.16	5.27	2.11	1.05	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.96	5.94	6.47	3.67	2.27	2.10	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	44.97	7.43	5.42	5.62	2.41	1.81	0.60	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.34	4.65	6.05	4.65	1.86	2.09	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.79	5.52	5.76	5.04	2.64	0.96	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	46.79	7.45	8.94	4.17	3.58	1.79	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	50.03	5.27	5.27	5.98	3.59	1.68	0.96	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.02	6.47	4.45	3.64	2.83	1.62	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	36.48	7.38	5.74	5.53	2.87	3.07	1.02	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	39.80	5.56	6.23	5.34	4.45	2.45	1.33	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	0.00	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.36	6.03	8.16	4.61	3.90	1.77	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.81	4.97	5.63	3.31	2.98	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.88	5.03	20.13	17.62	0.00	0.84	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.85	3.21	7.35	6.43	1.84	0.46	0.92	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.87	3.89	6.48	3.89	4.54	2.27	1.30	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.26	5.14	5.46	2.89	5.14	0.64	0.96	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.41	4.71	9.12	5.66	4.40	1.89	1.26	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	8.46	4.23	2.12	2.12	2.82	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	30.84	8.97	7.29	6.17	3.93	1.12	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	6.37	11.15	10.35	2.39	3.18	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.47	7.81	5.10	7.14	3.06	2.38	1.02	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.56	7.15	10.07	5.52	4.55	1.95	0.65	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.37	8.52	11.00	7.10	4.26	1.42	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	32.33	96.98	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	23.69	63.18	31.59	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.20	7.31	5.85	1.46	3.90	0.98	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	40.17	6.45	7.93	2.48	2.98	1.98	0.00	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.87	6.57	9.85	4.69	5.63	2.35	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	9.27	8.61	5.96	1.99	4.31	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	36.81	4.02	4.33	4.95	3.40	2.47	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	44.64	8.87	4.59	4.59	5.20	1.83	0.31	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	24.39	3.64	3.48	3.17	1.27	0.48	0.16	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	23.42	4.33	4.65	2.41	1.93	0.00	0.32	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	24.17	3.56	4.20	3.94	2.16	0.25	0.51	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	14.95	2.24	5.98	3.74	1.49	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	13.73	2.68	3.01	6.36	0.33	1.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	14.67	1.28	3.83	2.55	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	1.10	3.30	3.30	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.36	1.81	5.87	0.90	0.90	0.45	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	18.94	2.78	3.48	3.13	1.39	0.17	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	27.77	2.93	2.93	0.98	1.56	0.59	0.78	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	16.47	1.54	2.32	1.80	1.03	0.26	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	20.07	1.67	0.84	1.39	2.51	0.28	0.28	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	2.94	1.18	0.00	0.59	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	50.99	11.74	15.52	21.88	2.01	0.56	1.53	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	23.56	1.94	2.90	2.90	1.61	0.32	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	2.67	3.20	5.33	2.67	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	31.16	5.56	3.90	6.68	2.23	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.94	7.07	2.91	12.48	2.08	0.42	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	20.34	3.27	1.76	3.77	1.51	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	31.09	3.93	4.91	9.49	0.98	0.33	0.00	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	27.10	3.96	5.48	6.70	1.52	0.00	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	16.80	5.75	5.52	5.08	0.88	0.00	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	1.08	1.08	2.51	0.00	1.43	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	1.20	2.40	3.59	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.29	2.16	3.42	3.06	1.08	0.18	0.90	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	0.00	0.00	3.35	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.01	1.23	5.55	4.73	2.05	0.00	1.03	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	30.67	2.63	3.78	1.60	2.06	0.34	0.23	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	22.04	2.69	2.20	1.71	1.47	0.00	0.73	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.26	5.84	4.94	8.99	1.80	2.25	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.05	6.08	4.34	8.25	3.47	0.87	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	4.28	0.00	0.00	4.28	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.31	3.89	4.78	6.88	1.49	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	7.59	5.06	6.32	2.53	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	5.94	0.66	2.64	1.98	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.82	6.17	2.92	8.12	1.30	0.65	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	32.04	7.77	4.37	8.25	0.97	0.00	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	18.41	1.78	5.34	5.94	0.59	1.78	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.38	7.53	3.39	7.91	3.01	1.51	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	4.35	5.08	12.34	0.73	0.73	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	12.54	2.51	2.51	1.25	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	26.52	7.91	6.59	7.91	2.80	1.48	0.49	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	5.46	1.36	12.28	0.00	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.63	8.90	3.77	7.24	1.06	0.45	0.45	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	4.29	2.68	6.43	2.14	1.07	0.00	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.83	9.82	5.29	5.86	2.46	0.76	0.00	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.72	7.22	6.15	9.62	2.67	0.53	0.53	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	2.93	1.95	7.80	3.90	0.98	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	26.87	7.46	6.47	6.97	2.65	0.50	0.33	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	4.80	2.40	3.60	4.80	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	7.08	10.62	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.93	7.03	3.77	6.35	2.40	0.69	0.17	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	4.19	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.24	6.31	5.34	6.31	2.91	0.49	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.49	3.79	5.31	6.07	2.66	0.38	1.52	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	8.48	4.85	7.27	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.80	5.13	3.99	5.70	2.85	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.31	6.63	3.63	6.20	2.78	0.64	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.61	4.90	5.16	6.19	3.36	0.77	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.30	5.63	0.47	6.57	0.94	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.76	9.00	5.47	6.11	0.96	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	5.71	3.57	6.42	1.43	0.71	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	4.68	3.51	4.09	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.99	9.03	3.31	6.62	2.11	1.20	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	2.38	2.38	8.32	2.38	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.99	5.09	6.61	8.14	3.05	1.02	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.90	8.15	6.11	4.84	1.78	1.02	0.76	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	5.08	3.18	5.08	2.54	0.00	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	25.89	6.47	3.02	10.36	1.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.11	9.53	4.23	5.29	2.54	0.21	0.85	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.72	5.51	3.19	6.38	1.74	0.87	1.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	10.39	1.89	10.39	1.89	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.60	7.29	5.76	7.29	2.20	1.36	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	6.95	4.63	6.95	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	16.90	2.11	21.13	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.30	8.36	4.29	10.72	2.79	1.29	0.43	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	7.22	2.41	9.63	0.60	1.80	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	9.48	5.83	10.21	1.46	2.19	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.68	8.74	4.83	8.28	2.76	0.69	0.69	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	5.10	10.20	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	23.14	12.71	4.32	7.12	2.80	1.02	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	26.22	8.46	5.57	11.35	2.27	1.45	0.62	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.42	5.51	7.04	10.40	2.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	6.21	5.74	9.56	1.91	0.48	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.40	10.87	4.21	7.32	2.66	1.55	0.67	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	1.53	4.58	1.53	4.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.03	9.97	6.09	8.31	1.66	2.22	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	24.63	3.71	4.50	5.83	3.97	2.65	1.32	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	20.35	5.82	4.36	7.63	3.27	0.73	1.09	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	16.83	2.09	5.16	2.95	1.23	0.25	0.49	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	10.61	2.23	3.42	2.91	0.34	0.34	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	9.65	0.21	2.31	2.10	1.05	0.42	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	36.95	4.53	5.58	3.49	1.39	0.00	1.74	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	41.09	4.37	8.57	5.99	2.10	0.32	1.78	0.32	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	38.93	6.41	11.93	9.25	2.54	0.30	0.89	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	103.22	41.17	25.23	21.79	2.41	6.31	3.10	1.15	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	109.37	47.23	34.33	26.81	2.63	5.39	3.88	1.50	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	104.35	40.85	29.36	22.53	2.62	6.03	2.73	1.37	0.46
Basophils, donor1	12241-129G9	3.40	0.00	1.83	0.26	0.00	0.78	0.00	0.00	0.00
Basophils, donor2	12242-129H1	10.10	1.80	5.41	2.89	0.00	3.61	1.08	0.00	0.00
Basophils, donor3	12243-129H2	13.23	0.73	3.38	2.35	1.03	0.88	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	0.43	1.29	2.16	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	1.26	1.26	1.26	1.26	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.44	0.62	0.62	1.04	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	21.42	1.84	2.99	2.30	0.69	0.00	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	11.70	1.08	1.98	1.08	0.72	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	10.82	1.65	1.55	1.13	0.21	0.31	0.41	0.21	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	9.08	1.63	1.86	0.70	0.00	0.23	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	9.27	0.96	5.44	1.92	0.00	0.96	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.40	0.56	1.69	1.69	1.13	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	13.55	1.30	4.08	1.30	0.74	0.74	0.37	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	9.00	1.10	1.54	0.66	0.44	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.17	2.55	5.38	3.40	2.55	0.28	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	19.33	1.90	4.93	0.76	1.52	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.68	1.64	5.26	3.62	3.29	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	12.14	1.59	2.46	1.59	0.87	0.00	0.29	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	12.67	0.60	3.62	1.51	0.30	0.30	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.63	0.24	0.47	0.71	0.47	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	10.04	0.84	1.51	2.34	0.84	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	0.83	2.76	3.31	1.66	0.00	0.55	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.94	0.25	1.49	1.74	0.50	0.00	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.69	1.17	4.90	3.92	1.57	0.00	0.98	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.68	0.89	4.27	3.38	1.60	0.00	0.36	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.40	1.74	2.83	3.05	1.09	0.00	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.66	0.47	2.34	2.11	0.23	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	1.06	4.22	5.81	0.53	0.53	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	2.22	2.22	5.55	2.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.01	0.59	0.74	0.74	0.74	0.15	0.59	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.58	1.60	0.60	1.40	1.40	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5.00	0.62	1.67	0.83	0.83	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.69	1.60	1.60	0.69	1.37	0.23	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.37	1.13	2.71	2.94	1.13	0.00	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	0.44	1.31	2.62	0.44	0.00	0.00	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.37	0.54	2.15	2.96	0.81	0.27	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.53	1.40	3.31	2.27	1.57	0.00	0.35	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.00	1.26	3.37	2.95	0.42	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.57	1.29	4.23	2.76	1.10	0.00	0.55	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.57	0.35	2.11	4.58	2.47	0.00	0.35	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.09	0.44	2.19	3.51	1.32	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.55	0.87	2.96	3.84	1.22	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.55	1.12	1.49	1.86	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.54	0.86	2.37	3.23	1.29	0.00	0.86	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.74	0.41	4.09	3.69	2.46	0.00	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.13	2.09	3.48	6.26	1.16	0.23	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.50	0.93	3.71	2.78	0.23	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	10.46	0.87	2.83	1.74	1.09	0.00	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	9.24	1.39	2.31	0.69	0.69	0.23	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	15.60	1.52	4.12	2.60	0.87	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	16.35	0.78	2.49	1.09	0.62	0.00	0.31	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	13.80	0.87	2.45	1.40	0.52	0.00	0.17	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	18.95	1.11	4.68	2.23	2.23	0.22	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	9.95	0.51	2.30	1.02	0.51	0.00	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	5.93	0.66	1.76	1.54	0.88	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	11.16	1.05	4.00	1.26	0.84	0.00	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	14.23	16.26	16.26	4.06	12.19	0.00	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	71.87	20.34	29.83	31.86	2.03	8.14	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	62.14	22.78	23.82	37.28	3.11	6.21	8.28	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	62.37	11.19	21.32	24.52	1.07	5.33	2.67	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	68.08	16.62	24.66	28.95	3.75	5.90	6.97	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.09	16.14	30.18	32.29	2.11	4.21	6.32	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.90	30.59	21.18	29.02	0.78	8.63	9.41	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	69.87	19.77	27.68	26.37	1.32	5.27	7.91	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	60.82	22.19	36.99	36.99	2.47	4.11	3.29	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	68.19	17.41	14.51	20.31	0.00	3.63	5.08	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	57.55	10.60	25.75	29.28	1.01	5.05	5.55	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.93	0.40	2.42	1.62	0.00	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	11.19	0.40	3.20	1.60	1.20	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	7.03	2.01	1.00	2.01	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	4.49	0.56	1.12	2.25	0.00	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.53	5.64	6.39	7.14	0.00	1.13	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.33	4.28	14.21	8.57	0.45	1.58	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	3.21	0.00	1.43	0.71	0.00	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	6.12	1.84	5.51	1.84	0.00	3.06	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	10.67	2.13	4.88	2.13	0.00	3.05	0.61	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.04	0.26	0.00	0.51	0.00	0.00	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	6.51	0.90	1.35	0.22	0.00	0.22	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.31	0.29	0.00	0.29	0.00	0.57	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.32	0.47	2.84	0.47	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.75	0.00	3.51	0.70	0.70	1.40	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	6.21	1.30	3.03	0.58	0.29	3.32	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	6.27	0.34	2.03	1.19	0.00	0.85	0.34	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.83	1.45	3.87	1.13	0.48	3.87	0.16	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	2.69	4.03	1.79	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.22	5.24	6.99	3.14	0.35	1.75	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	10.56	1.76	6.16	3.08	0.00	4.84	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	6.75	1.69	2.11	0.42	0.00	0.84	1.26	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.64	1.66	2.91	0.00	0.21	1.45	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	12.70	1.67	1.67	0.67	0.33	4.01	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.82	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.07	1.07	2.14	1.07	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	0.00	0.00	0.00	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	7.05	0.74	2.23	0.56	0.37	1.67	0.93	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	9.75	0.87	2.38	1.30	0.00	4.12	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	15.97	2.94	3.78	0.84	0.42	7.57	1.26	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.07	1.52	4.04	2.53	0.00	1.01	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.56	0.43	5.63	2.17	0.00	5.20	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	14.82	1.31	6.97	2.61	0.44	11.77	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	8.41	1.48	2.47	0.00	0.00	1.48	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	3.69	0.00	1.85	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	1.40	1.40	0.00	1.40	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7.20	1.94	4.71	1.11	0.28	2.49	0.83	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	5.15	1.23	2.45	1.23	0.00	2.45	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3.08	0.00	0.00	1.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.39	1.79	0.72	0.72	0.72	1.07	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	4.15	2.77	0.00	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	3.60	1.64	1.64	0.33	0.00	3.60	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	5.26	0.75	3.00	0.38	0.00	3.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	1.51	0.50	0.25	0.00	0.00	0.25	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	26.38	16.52	11.24	14.22	0.92	2.98	1.84	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.77	16.30	10.06	15.82	0.96	1.68	1.68	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.34	13.13	15.59	16.42	0.82	1.64	0.55	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.92	19.81	15.01	15.01	1.20	3.30	1.80	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.64	20.64	11.52	11.28	1.44	0.96	1.20	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.15	20.69	15.46	16.37	1.36	2.05	1.59	1.82	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.25	22.60	14.12	12.82	0.43	1.30	0.87	0.87	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.06	23.69	10.53	15.79	1.32	2.63	1.05	1.58	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.80	18.06	14.31	11.26	0.70	2.81	1.88	2.35	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	22.64	27.77	9.66	11.17	2.11	2.11	1.21	3.02	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.04	21.50	12.49	9.01	1.74	0.58	1.74	1.74	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	25.04	30.11	12.26	12.26	1.07	1.07	1.87	2.93	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	35.02	18.39	23.64	0.44	4.82	2.63	3.06	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.98	35.98	17.76	23.23	1.37	0.91	1.82	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	39.53	16.41	23.12	0.00	1.49	2.98	4.48	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	27.73	21.61	15.13	20.17	0.36	3.96	2.88	2.16	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	32.80	23.59	13.81	18.41	0.86	2.01	1.73	2.01	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	29.23	21.21	13.91	16.26	0.47	2.59	1.89	1.18	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.96	23.45	16.48	15.53	0.63	1.58	1.90	2.22	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	32.29	21.53	14.46	12.30	1.54	1.85	1.85	1.54	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.36	21.48	16.99	14.43	0.96	0.96	1.92	1.92	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.24	28.30	13.77	15.68	0.76	3.44	1.91	1.91	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.41	28.77	16.16	15.76	0.79	1.58	2.76	2.36	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	25.72	23.45	9.08	9.83	1.51	2.27	2.27	4.54	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.84	55.40	44.97	44.16	2.41	4.01	5.62	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	78.34	52.46	39.87	48.96	2.80	3.50	5.60	4.90	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	59.10	47.08	45.08	5.01	11.02	2.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	14.62	3.66	1.83	10.97	0.00	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	18.78	3.46	2.96	2.47	1.98	0.49	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	22.31	5.47	7.05	4.84	1.79	0.53	0.00	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	26.00	0.69	1.73	2.08	2.43	0.00	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.86	3.20	1.78	1.78	3.55	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	22.41	2.39	2.39	1.59	1.93	0.00	0.34	0.11	0.00
Chondrocyte - re diff, donor2	11339-117F7	11.64	4.48	1.79	1.79	3.58	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.77	4.45	3.24	2.02	0.40	0.81	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	32.94	4.36	6.77	3.67	1.84	0.23	0.80	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	25.01	3.21	6.84	4.06	1.92	0.21	0.86	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	30.35	5.75	5.31	5.58	0.80	0.35	0.97	0.00	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	35.49	6.42	5.87	3.76	1.38	1.01	0.73	0.09	0.00
Corneal Epithelial Cells, donor1	11526-119I5	6.81	1.32	0.66	1.10	0.44	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	0.00	1.14	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.01	1.02	2.30	0.26	0.51	0.00	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.31	0.66	1.65	0.00	0.50	0.00	0.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	17.03	1.26	2.52	0.63	1.26	0.00	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.17	0.86	1.30	0.43	0.22	0.00	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	235.39	76.19	287.32	234.71	2.05	63.20	8.88	1.02	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	164.52	62.02	223.28	189.99	3.92	73.77	9.79	2.61	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	208.10	60.01	216.32	264.23	2.42	70.17	7.74	1.45	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	28.18	42.03	8.67	8.00	3.84	2.33	0.67	1.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	18.78	24.64	4.11	2.93	4.69	2.35	0.00	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	19.80	38.46	9.62	9.62	4.52	0.85	0.57	2.83	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	18.87	50.33	11.40	12.58	5.50	0.79	1.18	3.54	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.76	13.96	5.82	8.44	2.33	0.87	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	28.94	39.06	11.53	13.65	3.29	3.06	1.18	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	23.84	38.39	9.29	7.89	4.56	1.40	1.40	1.05	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.28	32.58	7.98	12.19	3.99	1.11	1.55	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.17	43.51	9.13	13.69	5.48	1.83	1.22	2.13	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.83	34.96	10.15	9.58	4.79	2.54	0.56	1.41	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	18.13	21.10	3.86	5.05	4.16	0.30	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	11.98	21.35	9.89	5.21	2.08	0.52	1.04	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	19.00	16.31	3.54	3.54	2.41	0.00	0.28	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	19.61	29.61	7.60	7.60	5.60	1.60	1.60	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	14.68	15.20	14.68	0.52	1.05	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	34.29	40.75	14.91	10.81	4.97	1.24	1.24	1.99	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.76	25.85	8.47	7.82	4.78	0.22	0.43	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	35.42	40.67	14.90	9.77	3.79	0.73	1.22	1.10	0.37
Endothelial Cells - Vein, donor1	11267-116G7	19.34	27.30	4.55	7.96	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	26.54	9.08	6.99	5.59	2.10	0.00	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	17.74	20.41	8.01	4.71	2.51	1.26	0.16	1.10	0.47
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65	0.00	0.00	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.06	0.49	0.73	0.49	0.49	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	28.33	5.34	5.34	2.46	3.28	0.41	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.50	2.63	1.31	2.19	0.99	0.44	0.22	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.03	2.93	3.79	3.47	1.95	0.43	0.43	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.99	9.34	8.49	8.13	1.58	1.21	0.49	0.49	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.83	4.64	3.82	4.23	1.23	0.68	0.41	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.57	2.53	2.43	1.37	1.90	0.11	0.84	0.00	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.08	1.58	4.48	3.95	0.00	0.79	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.22	4.98	9.63	2.33	2.33	0.66	0.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	18.15	4.54	5.90	6.35	1.81	0.45	0.91	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	10.61	0.76	9.10	3.79	0.76	2.27	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.19	3.47	5.99	3.79	1.10	0.47	0.47	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	28.80	14.55	13.34	12.73	3.33	0.91	0.30	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	31.22	10.91	8.12	9.90	3.81	1.02	1.52	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	26.53	15.61	15.92	14.86	3.64	1.67	0.76	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.27	2.01	6.16	6.16	0.40	0.27	0.27	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	3.02	2.16	2.16	0.43	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	2.93	10.25	2.93	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	21.68	3.92	4.61	1.38	0.23	0.00	0.92	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	28.66	3.73	4.92	2.04	0.34	0.17	0.34	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	20.43	1.17	4.23	2.11	0.94	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	17.92	8.49	1.89	4.25	0.94	0.94	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	25.14	4.59	4.23	1.93	1.33	0.24	0.12	0.12	0.24
Fibroblast - Dermal, donor4	11450-119A1	18.09	2.26	3.96	2.49	0.90	0.00	0.45	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	21.28	2.27	2.44	1.74	1.22	0.17	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	18.03	2.92	4.71	1.46	1.30	0.16	0.97	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	23.32	2.92	2.29	1.67	1.87	0.21	0.21	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	29.08	2.62	4.72	1.31	2.36	0.26	0.00	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	27.81	3.56	6.06	1.84	1.45	0.92	0.66	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	25.14	2.03	3.77	0.68	1.06	0.10	0.29	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	25.97	4.16	5.19	1.04	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.14	2.64	3.35	1.94	1.76	0.53	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.11	4.21	3.12	1.40	1.25	1.56	0.94	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.37	1.62	2.57	1.08	1.49	1.08	0.41	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.23	1.41	3.53	3.53	0.00	2.12	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.57	2.63	4.97	1.17	1.32	0.15	0.29	0.00	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.18	1.50	2.59	1.77	2.18	0.27	0.14	0.00	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.01	2.19	2.74	1.21	0.77	0.99	0.33	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.86	1.47	5.14	1.91	1.91	0.29	0.59	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	20.39	4.08	4.08	6.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	11.94	5.97	5.97	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	33.98	10.34	6.96	6.33	1.27	1.27	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	2.50	0.83	3.33	0.83	2.50	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	2.80	5.59	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	0.56	1.40	2.24	0.28	0.00	0.56	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	23.95	4.87	3.25	3.25	1.22	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	5.96	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.16	3.10	4.46	1.36	1.36	0.19	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	29.27	4.25	5.16	1.82	2.28	0.15	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.31	6.12	5.51	1.53	1.84	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.74	1.91	3.05	1.91	0.76	1.53	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.38	1.08	2.43	1.08	2.43	0.27	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	23.43	2.90	3.13	1.04	0.81	0.35	0.12	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.94	16.36	15.47	14.48	2.65	2.76	1.22	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.37	5.89	9.96	7.72	1.02	0.81	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	2.00	2.67	1.34	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.98	1.98	4.35	1.98	1.98	0.79	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.03	2.38	8.73	6.95	0.60	1.19	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	18.29	4.80	5.68	2.84	2.13	0.53	0.18	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.45	1.58	4.34	6.90	2.56	0.79	0.59	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.17	2.41	4.51	5.72	0.60	0.60	1.20	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.80	2.91	3.67	2.70	2.48	0.32	0.54	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.80	1.52	7.85	4.81	1.27	0.00	0.76	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	22.31	2.30	4.92	4.10	1.80	0.49	0.49	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.07	4.21	5.01	4.41	1.60	0.20	1.20	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	26.22	1.81	3.52	3.32	2.21	0.10	0.90	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	24.18	1.51	6.35	2.12	1.21	0.91	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.11	2.24	3.98	3.56	1.82	0.58	1.16	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.98	2.56	4.10	3.93	2.74	0.17	0.85	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.66	3.61	7.55	6.24	1.31	0.99	0.66	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.32	4.79	7.03	6.39	3.20	0.75	0.75	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	27.83	6.24	6.41	5.90	1.52	1.35	0.17	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	20.70	3.29	4.86	3.14	2.20	0.47	0.78	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	22.16	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	2.61	2.61	0.00	0.00	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	35.71	5.20	3.12	4.85	2.43	0.52	0.52	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.45	6.51	5.47	7.03	3.12	0.78	2.08	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	32.71	4.85	2.81	2.30	1.28	0.51	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	7.66	0.77	0.00	1.53	0.00	0.77	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	11.49	1.28	0.64	0.00	1.28	0.00	0.64	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	16.83	4.56	2.85	4.28	2.57	0.00	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.36	4.69	7.45	14.89	0.55	0.28	4.96	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.63	3.88	5.48	7.53	0.68	1.14	2.97	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.23	5.75	1.98	6.74	0.99	0.00	2.77	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.41	7.14	10.31	13.75	1.59	0.26	5.02	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.37	5.54	6.20	3.91	0.98	0.33	1.96	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	6.19	2.21	3.10	3.98	0.44	1.33	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.86	2.12	2.83	1.27	0.28	0.14	0.71	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	19.70	4.93	2.71	3.08	1.60	0.00	0.62	0.25	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.13	2.42	2.69	2.69	1.61	0.00	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.23	12.64	7.56	10.65	3.47	0.25	1.36	0.50	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.73	17.16	10.80	11.77	2.08	0.55	1.80	0.69	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.84	8.13	6.51	9.56	0.61	0.61	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	22.59	11.41	5.93	6.62	0.91	0.23	1.37	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.40	16.44	7.72	9.09	1.37	0.25	1.37	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	25.57	17.49	5.25	4.81	2.19	0.22	1.31	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	7.68	5.02	2.36	1.18	0.30	1.77	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.96	6.84	6.20	8.42	1.43	0.32	1.11	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.77	11.62	2.23	3.13	0.67	0.67	1.79	0.22	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.55	5.24	6.65	5.44	1.61	0.00	0.60	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.21	6.79	6.45	6.96	2.04	0.34	1.02	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.51	9.58	3.55	3.64	1.51	0.27	0.44	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.87	3.75	4.79	4.16	1.77	0.31	1.66	0.21	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.27	3.59	4.78	4.61	2.05	0.68	0.85	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.80	4.43	3.76	6.20	1.55	0.11	1.44	0.11	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.64	6.41	4.99	3.00	1.16	0.00	1.00	0.17	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.76	4.70	3.88	4.49	1.63	0.61	0.41	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.71	4.33	2.89	5.57	2.27	0.21	1.03	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.25	3.57	5.65	4.27	1.61	0.23	0.81	0.23	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	16.84	3.17	4.00	3.17	2.17	0.50	1.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.97	2.20	3.97	2.65	0.66	0.00	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.26	2.09	3.44	5.53	1.48	0.25	1.35	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	17.02	4.86	4.21	3.57	1.62	0.49	1.46	0.16	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	19.24	4.81	5.13	3.21	0.32	0.64	1.60	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.17	3.13	4.45	3.03	1.04	0.47	0.28	0.09	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.18	4.43	3.32	2.53	0.79	0.00	0.47	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.77	1.82	4.87	1.82	2.43	0.30	0.91	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.82	3.14	4.08	2.51	1.15	0.10	0.42	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.61	3.07	4.61	1.32	1.10	0.00	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.11	3.37	2.24	1.96	2.52	0.00	1.12	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.24	2.13	3.24	2.78	1.30	0.37	0.93	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	3.48	5.35	2.94	1.34	0.27	0.53	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.50	2.14	3.52	3.21	1.38	0.15	0.92	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.95	3.63	4.15	4.02	1.17	0.26	0.26	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.69	3.25	3.80	1.63	1.08	0.27	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.80	2.58	6.08	2.77	1.84	0.00	0.18	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.01	1.75	4.17	1.97	1.32	0.00	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	3.97	3.97	2.98	3.97	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.94	2.51	3.96	2.90	0.92	0.40	0.66	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.75	2.82	3.83	2.22	1.41	0.20	1.01	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.86	3.56	5.08	2.29	1.27	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.37	1.99	1.00	1.00	1.39	0.00	1.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.40	2.31	1.54	1.08	0.00	0.15	0.46	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.34	2.66	2.25	1.64	0.61	0.00	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.64	2.19	2.19	2.82	1.25	0.31	0.94	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.43	1.13	1.70	0.85	1.41	0.28	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.30	2.31	1.84	1.84	0.92	0.46	1.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	7.42	0.00	0.00	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.70	3.09	3.09	3.48	1.16	0.00	0.77	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	0.00	1.60	1.60	3.21	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	3.48	6.96	5.22	0.00	0.00	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.58	1.30	2.93	2.93	0.98	0.65	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.88	2.88	4.53	3.29	1.65	0.00	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	3.33	0.00	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.38	1.68	2.80	4.19	1.12	0.00	0.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.05	3.27	4.25	6.21	0.65	0.00	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	14.26	2.52	0.84	2.52	0.00	0.00	2.52	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.45	4.13	3.18	2.54	1.27	0.32	1.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	16.30	3.40	3.06	4.08	1.36	0.00	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	4.18	0.00	0.00	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.76	2.86	4.58	1.72	1.15	0.00	2.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.43	2.66	2.07	2.07	0.59	0.00	0.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	23.72	5.08	1.69	3.39	0.00	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.54	3.31	3.73	5.80	0.83	0.83	1.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.73	2.99	3.68	4.14	2.30	0.46	0.46	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	5.27	15.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.99	1.92	2.69	2.69	0.38	0.00	0.77	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.60	2.93	3.91	2.61	1.96	0.33	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	4.01	2.68	2.68	0.67	0.00	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	22.35	4.24	5.78	4.24	1.54	1.16	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	17.80	5.48	4.79	5.82	1.03	0.34	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	9.94	2.48	4.97	2.48	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.23	5.19	4.72	4.25	2.36	0.00	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	17.50	2.41	5.43	4.22	1.81	0.60	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	3.56	3.56	3.05	3.56	1.02	1.02	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	17.55	3.99	5.58	5.58	0.80	0.00	0.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	4.93	4.93	2.47	3.45	0.99	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	2.36	4.72	2.36	3.54	2.36	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.26	3.50	4.08	7.00	2.33	1.17	1.17	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	3.51	2.19	5.71	2.63	0.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	4.24	5.93	4.24	1.70	0.85	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	15.52	2.39	5.37	2.39	0.00	0.00	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.38	1.94	5.34	5.34	0.49	0.49	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	3.42	5.71	9.13	1.14	0.00	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.55	3.33	7.07	4.16	0.83	0.42	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	26.99	6.75	4.50	5.62	2.25	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.03	2.54	5.07	2.85	1.27	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.19	1.67	2.09	3.34	4.18	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.68	2.32	2.67	3.02	1.97	0.12	0.70	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.53	3.54	4.73	5.91	0.51	0.34	0.84	0.68	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.83	2.28	2.50	4.10	0.91	0.46	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.87	2.08	4.81	5.25	0.33	0.22	0.77	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.68	1.93	5.16	4.94	0.64	0.00	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.49	1.94	4.31	4.31	0.86	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.71	1.62	1.62	3.36	0.75	0.12	0.62	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.44	2.06	4.80	2.92	0.86	0.00	1.03	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.21	2.24	2.24	3.20	0.00	0.32	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	19.03	5.60	11.75	1.68	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	1.73	6.49	6.49	0.43	0.87	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	31.73	7.93	21.15	0.00	0.00	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	17.99	4.94	2.47	3.17	1.41	1.06	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	0.00	3.63	3.63	2.18	0.73	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.46	4.20	4.55	2.45	1.40	1.05	0.52	0.35	0.00
Hepatocyte, donor1	11523-119I2	25.42	12.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	30.17	44.17	0.00	0.00	3.23	0.00	0.00	3.23	1.08
Hepatocyte, donor3	11684-122I1	28.84	14.72	1.23	1.84	1.23	0.00	0.00	2.45	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.00	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.35	3.32	4.54	4.02	2.10	0.00	1.22	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	22.50	5.08	5.76	5.49	1.78	0.55	0.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	0.00	1.62	3.25	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	1.67	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	3.63	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	0.00	3.97	2.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	1.11	1.11	0.00	2.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.64	0.63	1.89	0.63	0.00	0.00	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	3.09	0.00	1.55	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	3.23	0.65	3.88	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	3.26	0.81	0.00	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.72	1.26	0.42	1.26	0.00	0.00	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	4.82	0.00	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	4.25	0.94	1.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	1.81	0.91	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	2.15	3.23	2.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	3.81	1.27	0.00	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	9.57	1.28	1.91	0.00	0.00	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	1.82	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	2.14	1.43	0.71	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.11	1.85	0.62	0.31	0.00	0.00	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	1.74	0.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	1.07	0.00	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	1.39	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	0.00	0.92	0.00	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	3.17	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	12.65	2.12	2.77	2.12	0.57	0.16	0.16	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	2.93	2.93	1.76	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.83	3.12	2.93	2.18	0.66	0.00	0.28	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	22.93	2.95	3.41	2.95	1.25	0.34	0.34	0.00	0.11
Keratocytes, donor1	11527-119I6	19.60	2.41	2.06	1.03	0.34	0.34	1.03	0.00	0.00
Keratocytes, donor2	11607-120I5	11.72	7.03	11.72	5.86	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	19.96	2.17	1.58	0.79	1.19	0.40	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	4.40	2.20	2.20	0.00	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	4.31	6.47	8.63	2.16	0.00	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	22.72	3.46	2.54	1.38	1.04	0.12	0.69	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	20.08	5.85	7.06	7.47	1.41	0.40	1.11	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.31	22.29	6.76	6.64	3.68	0.59	1.30	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.35	8.65	3.91	5.02	2.23	0.28	0.56	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	26.29	15.27	6.45	4.56	3.15	0.00	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	12.91	3.23	4.84	3.23	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	23.64	11.66	4.41	4.41	1.58	0.95	0.63	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.85	12.29	2.91	5.39	2.26	0.22	0.32	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.16	10.67	4.10	9.03	2.87	0.41	0.00	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.91	8.60	2.28	3.29	1.77	0.25	0.76	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.05	11.68	3.38	3.38	1.55	0.42	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.59	15.43	4.35	7.12	2.37	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.19	11.63	3.68	5.82	2.91	0.00	0.39	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.70	9.26	3.70	3.70	1.67	0.19	0.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	22.30	13.59	4.88	5.23	4.53	0.35	0.35	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.13	8.11	3.10	2.86	2.62	0.95	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.83	10.85	3.98	4.94	1.92	0.00	0.55	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.02	14.78	5.24	7.39	3.39	0.62	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.28	8.42	2.49	4.68	1.87	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.49	10.25	5.12	3.84	2.56	0.00	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	19.09	14.81	4.94	5.92	2.96	0.66	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.82	9.96	3.22	4.98	1.76	0.29	0.00	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.21	8.21	3.24	5.23	2.49	0.00	0.75	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.03	19.40	7.76	7.27	0.97	0.00	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.93	12.93	3.77	5.92	2.96	0.27	1.08	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.40	12.56	3.63	6.06	2.42	0.45	0.76	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.66	14.00	4.67	6.22	2.59	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	21.99	13.82	3.14	6.28	1.68	0.84	0.84	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.49	9.92	1.95	3.16	2.11	0.75	0.45	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	19.26	4.13	4.13	4.82	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.06	12.98	3.39	6.02	0.56	0.94	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	15.06	9.65	2.54	3.61	1.27	0.42	0.53	0.53	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.93	12.60	5.81	9.69	2.91	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	9.26	2.98	2.65	1.65	0.33	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.99	10.16	3.72	2.35	1.98	0.62	0.62	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.03	18.88	5.92	5.18	2.22	0.00	1.48	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.58	9.14	1.48	6.42	0.74	0.25	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.16	9.21	3.02	2.89	1.79	0.41	0.69	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.44	18.01	5.47	7.08	2.25	0.32	1.29	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.87	13.69	3.96	6.39	2.43	0.61	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.58	13.16	4.06	3.08	2.94	0.28	0.14	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.11	16.36	3.91	4.27	3.91	0.00	0.71	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	10.18	2.42	5.33	2.91	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.29	8.25	2.49	2.96	1.71	0.00	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.77	11.82	4.30	5.37	1.43	0.72	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.37	8.82	2.94	2.94	1.96	0.98	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.12	7.06	2.35	1.41	0.71	0.00	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.89	15.35	5.45	5.69	2.48	1.49	0.50	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	8.45	1.54	3.33	2.05	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	11.04	3.58	3.58	1.19	0.00	0.00	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	0.00	0.74	1.48	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.46	0.00	1.27	0.85	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	0.70	2.11	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	0.00	1.87	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	0.52	0.52	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.27	0.45	0.23	0.23	0.00	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	0.58	2.62	1.16	0.58	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	1.35	2.25	0.45	0.00	0.00	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.89	0.81	1.08	0.81	0.27	0.00	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	1.03	1.03	1.03	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.00	1.06	0.71	1.06	0.35	0.00	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.00	1.33	0.67	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	1.02	2.04	1.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.08	1.87	0.53	0.27	0.27	0.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.12	0.94	1.51	0.57	0.19	0.00	0.19	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	0.00	1.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.97	0.00	2.45	1.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.49	0.00	1.67	0.83	0.62	0.00	0.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.65	1.12	1.68	0.00	0.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	0.00	2.06	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.77	0.58	0.87	0.29	0.87	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.26	0.00	1.49	0.00	0.00	0.30	0.60	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	0.71	2.47	1.06	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.48	1.48	0.74	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	0.00	0.00	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.13	0.77	0.77	0.38	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	0.00	1.13	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.85	0.00	0.82	0.00	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.68	0.45	0.45	0.90	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	0.72	1.44	0.00	0.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.98	0.00	1.49	1.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.40	0.74	1.49	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.06	1.29	0.86	0.43	0.43	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.86	0.00	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.66	0.00	2.00	1.33	0.00	0.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	0.60	1.81	0.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	1.42	0.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	2.41	0.00	1.03	0.00	0.00	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	0.54	0.54	0.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	0.67	1.35	0.00	0.00	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.33	0.00	1.48	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	0.00	2.33	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	0.00	3.17	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.40	2.00	0.80	0.40	0.00	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	0.00	0.73	0.73	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	0.00	1.48	0.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	0.00	1.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	1.01	1.01	1.01	1.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.97	0.00	1.35	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	0.00	0.00	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.47	0.45	0.00	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.78	0.39	0.39	0.00	0.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	0.66	0.66	1.32	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	12.97	1.04	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	1.31	1.31	0.88	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	10.62	0.56	2.24	0.56	0.56	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.57	0.00	0.00	0.00	0.44	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13.11	1.54	1.54	0.39	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	0.51	1.01	1.01	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.53	0.00	1.44	0.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.75	1.59	1.19	0.40	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	0.00	0.61	1.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	9.68	0.69	0.00	1.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.60	0.38	1.14	1.14	0.38	0.38	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.78	1.03	0.52	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	0.00	0.60	0.60	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.04	1.27	0.63	0.95	0.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.33	0.53	0.53	0.00	0.53	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	0.00	1.15	1.15	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	0.00	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	0.00	2.83	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	0.00	0.57	1.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	0.42	1.66	0.00	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	0.00	0.00	2.35	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	6.68	0.42	0.84	1.25	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	0.00	0.93	0.93	0.00	0.00	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	1.34	0.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.35	1.60	0.00	0.53	1.07	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.91	0.00	2.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	9.18	0.00	0.92	0.92	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	1.14	0.57	1.14	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	5.37	0.77	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	0.00	1.64	0.55	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.80	0.00	0.89	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	0.26	1.56	0.78	0.00	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.95	0.00	0.66	1.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	17.78	2.05	3.87	1.60	2.51	0.00	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	10.83	1.10	1.47	0.55	0.55	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	19.79	1.44	2.75	2.49	1.05	0.00	0.26	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	30.80	4.25	2.66	2.66	3.19	0.53	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	24.56	6.81	4.75	4.75	1.90	0.48	0.79	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	18.21	6.25	3.06	3.47	2.50	0.28	0.69	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	56.40	11.06	4.88	2.99	2.39	0.50	0.80	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	26.93	3.47	3.76	3.19	0.87	0.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	22.70	2.49	2.00	0.75	1.75	0.00	0.75	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	6.10	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	2.05	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	12.18	2.67	0.89	0.00	0.30	0.59	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	12.83	0.68	2.03	0.00	0.23	0.68	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	3.72	1.06	0.18	0.18	0.18	0.00	0.00	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	6.43	0.55	0.67	0.55	0.67	0.00	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	3.50	0.00	0.58	0.00	0.00	0.00	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	2.64	0.00	0.23	0.00	0.34	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.84	0.17	0.00	0.00	0.50	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	35.22	52.24	9.25	9.65	4.58	1.39	0.80	1.39	0.30
Melanocyte - dark, donor2	11582-120F7	21.46	4.15	2.08	3.81	2.77	1.38	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	28.03	6.01	4.78	1.16	2.39	0.00	0.58	0.00	0.29
Melanocyte - light, donor1	11274-116H5	12.69	3.53	1.65	0.94	2.12	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	9.55	4.09	3.41	2.73	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	17.34	0.87	0.87	0.00	0.87	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	28.01	4.37	10.62	6.04	1.35	0.10	0.73	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	23.67	7.26	4.30	3.77	1.34	0.54	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	30.80	10.18	6.16	5.62	4.55	1.07	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	17.74	2.85	10.30	6.58	0.99	0.37	0.74	0.12	0.25
Meningeal Cells, donor2	11573-120E7	24.21	4.84	6.16	4.84	2.20	0.88	2.20	0.00	0.00
Meningeal Cells, donor3	11654-122E7	26.24	5.71	12.06	9.70	1.96	0.49	1.06	0.08	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.24	4.28	2.85	3.14	0.86	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.75	4.93	5.84	6.14	1.71	0.60	0.50	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	2.63	0.00	5.26	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	1.31	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	3.59	5.74	2.87	2.87	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	33.46	7.84	8.26	8.47	1.48	1.48	1.69	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	37.20	7.04	7.54	7.54	1.01	1.01	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.21	2.20	3.96	1.54	0.88	0.44	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	1.46	3.65	2.92	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	14.32	4.71	3.68	3.07	0.82	0.61	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.51	1.80	2.77	2.22	1.80	0.28	0.14	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	2.60	3.35	0.74	0.74	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	33.68	6.32	10.00	6.45	2.50	1.58	0.79	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.50	0.59	1.19	1.19	1.19	0.89	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	3.20	1.28	1.92	1.92	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.17	3.90	4.61	3.19	1.77	0.35	1.06	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	3.44	4.69	5.94	1.56	1.56	1.56	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	0.73	2.90	1.45	0.73	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	29.17	3.71	4.24	3.71	2.92	0.53	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	24.52	7.01	2.50	6.01	3.00	0.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	32.37	6.07	5.71	6.00	2.67	1.66	0.29	0.07	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	1.35	1.35	2.70	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.66	1.72	5.42	1.23	2.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.96	1.18	3.53	0.00	0.88	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.05	0.31	2.48	2.17	0.00	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.41	1.66	2.07	0.00	1.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	1.75	3.50	1.75	1.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	1.40	1.40	0.47	1.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.62	1.63	4.47	1.83	1.42	0.20	1.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	16.63	2.77	4.36	1.98	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	0.88	4.42	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.48	1.52	2.28	2.66	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.40	1.70	3.61	3.61	1.49	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	1.84	2.76	0.00	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	2.09	3.58	3.87	1.49	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	3.35	3.35	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.30	1.76	3.26	2.01	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	11.65	1.90	3.33	3.09	0.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.74	0.55	1.66	0.55	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	16.12	1.15	6.91	6.45	1.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.35	3.37	5.26	3.79	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.21	1.83	4.48	5.50	0.61	0.20	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.45	1.29	5.58	4.93	1.07	0.21	0.00	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.34	3.33	5.56	5.78	0.44	0.00	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.26	2.85	8.98	5.04	1.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	2.53	1.01	3.55	1.01	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	4.97	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.12	5.16	8.97	7.88	2.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.64	1.76	7.35	6.18	1.18	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	2.18	3.27	2.18	4.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.26	3.36	12.49	13.94	3.84	0.00	1.44	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.21	4.80	10.41	9.61	1.20	0.40	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	10.97	5.48	4.11	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	23.03	7.01	14.52	21.02	1.50	1.50	2.50	0.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	2.04	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.90	14.01	22.33	42.92	3.07	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	6.62	1.10	2.21	3.31	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.82	10.25	8.33	3.84	2.56	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	38.43	18.10	26.03	35.95	3.22	1.24	1.24	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	17.40	2.78	2.09	6.96	2.78	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	8.84	4.42	2.21	6.63	4.42	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	33.16	16.07	13.68	27.69	5.47	0.68	0.34	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	5.25	2.19	5.69	1.75	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.41	7.46	4.26	8.88	2.49	0.36	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	48.25	23.29	24.41	34.79	3.93	1.68	0.84	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.20	6.23	2.91	6.23	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	6.99	5.83	6.41	2.91	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.63	17.80	22.02	26.24	4.52	0.30	0.90	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	6.26	6.26	8.77	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	16.62	17.55	17.55	4.62	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.32	3.98	5.69	9.11	1.14	0.57	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	26.25	9.53	8.15	10.23	2.35	0.14	0.41	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	44.31	18.14	26.43	33.95	2.59	1.81	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.46	7.72	7.72	5.15	0.86	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.15	6.35	5.08	3.81	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.56	20.82	20.82	24.29	4.80	2.14	1.33	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.74	4.19	5.09	6.59	1.50	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.17	5.23	8.62	8.76	1.41	0.57	0.00	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.04	21.34	18.47	36.31	3.19	2.23	0.32	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.29	5.75	7.74	5.31	1.11	0.44	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.03	6.83	7.20	7.20	1.52	0.76	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.29	14.21	20.17	29.55	2.56	1.42	1.14	0.57	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	33.68	6.15	6.64	7.37	1.47	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	3.26	3.26	2.61	1.30	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	44.69	11.17	16.76	20.29	2.65	1.76	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.10	2.88	3.75	4.61	2.31	0.86	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	4.53	6.18	4.53	0.82	0.41	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.05	8.64	8.04	5.96	2.38	0.89	1.19	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	3.77	11.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	3.56	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.36	1.64	4.27	1.97	4.27	0.00	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	0.00	2.10	2.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.85	0.59	2.37	1.98	0.99	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	0.00	3.73	3.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.77	0.75	2.25	2.63	5.26	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.92	0.53	0.27	1.07	1.86	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.73	0.90	3.96	1.13	2.26	0.00	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	0.74	1.47	2.95	1.47	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	1.83	1.83	1.83	0.37	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	0.00	1.56	0.00	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	0.00	3.74	1.07	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	1.01	0.00	3.03	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.90	0.42	1.69	0.00	1.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	1.36	1.36	0.00	5.45	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	0.00	1.27	0.64	3.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	13.77	3.24	2.43	2.43	0.81	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	1.51	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	13.05	6.52	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.75	10.77	15.08	15.30	2.15	1.72	0.65	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	5.23	9.41	6.79	1.57	0.52	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	2.00	2.67	0.67	2.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.71	3.34	4.59	1.67	2.09	0.00	1.25	0.83	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.96	4.18	8.37	6.27	2.66	1.33	1.71	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	11.17	4.79	6.38	17.55	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	2.04	4.08	0.68	3.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	5.51	16.54	12.86	1.84	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.09	2.51	1.67	2.93	0.42	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.03	4.18	5.81	3.72	1.63	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.65	1.62	3.24	2.43	1.08	0.00	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.55	2.73	3.15	2.73	1.68	0.42	0.84	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	2.48	0.99	3.47	1.49	0.50	0.00	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.84	2.17	1.89	3.52	0.81	0.00	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.08	2.04	4.31	3.85	1.59	0.68	0.45	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.74	1.63	4.25	3.10	2.29	0.49	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.05	3.10	3.10	1.09	1.46	0.18	0.18	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	3.18	3.71	5.83	2.12	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	23.41	1.20	2.40	2.40	1.80	1.80	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.36	0.66	6.56	5.91	1.31	0.66	0.98	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.12	2.60	5.04	2.60	2.28	0.81	0.65	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.22	3.35	3.17	2.47	1.06	0.35	0.53	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	20.39	2.11	3.52	2.11	3.52	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	24.82	0.92	3.68	2.76	2.76	0.92	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.06	2.25	3.21	1.93	1.29	0.00	0.64	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.97	3.45	11.04	10.69	1.72	0.34	0.34	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	2.53	17.70	10.11	5.06	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.82	3.12	5.79	2.23	1.78	0.45	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	2.12	2.96	2.12	2.12	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.79	1.66	2.85	3.80	1.90	1.19	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	31.76	4.29	4.29	3.43	1.29	0.00	0.86	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	0.00	9.03	45.14	9.03	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.99	1.33	4.00	3.00	2.00	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.03	1.80	0.90	3.16	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	0.79	3.97	6.75	0.40	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	1.86	5.57	2.79	2.79	0.00	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	3.03	3.41	2.65	2.27	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.27	2.28	6.52	5.87	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.02	4.36	2.61	1.31	1.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	3.62	4.07	2.26	3.62	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	4.41	3.53	3.53	1.76	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	2.66	3.32	5.32	1.99	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	3.97	4.96	2.98	1.49	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	2.30	3.45	3.06	0.77	0.38	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	1.81	7.26	3.02	2.12	1.21	0.00	0.00	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.01	2.65	6.63	3.98	1.77	0.00	1.11	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	4.07	4.74	4.74	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	10.22	20.44	25.55	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	2.44	4.88	2.44	1.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.16	3.78	3.78	2.83	2.20	0.31	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	22.40	2.12	5.75	1.21	0.91	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	4.75	4.75	3.96	2.37	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	2.27	14.74	11.34	2.27	2.27	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	5.06	15.17	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	23.23	7.21	5.47	6.96	1.86	0.50	1.24	0.37	0.25
Myoblast, donor2	11322-117D8	26.27	5.75	10.16	5.37	1.34	0.38	1.34	0.19	0.00
Myoblast, donor3	11398-118D3	25.06	4.71	5.38	2.69	2.19	0.50	0.50	0.34	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	16.91	2.46	5.23	1.54	0.31	5.23	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	8.44	2.11	4.52	0.60	0.60	3.32	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	7.91	1.66	2.39	0.92	0.18	1.10	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	29.76	2.54	8.71	5.08	2.18	1.09	1.45	0.00	0.36
Neural stem cells, donor2	11352-117H2	42.36	9.63	36.59	23.11	5.78	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	26.17	2.28	22.76	15.93	2.28	1.14	1.14	2.28	0.00
Neurons, donor2	11574-120E8	30.60	3.08	23.34	12.99	0.88	1.76	3.30	0.22	0.00
Neurons, donor3	11655-122E8	35.35	1.64	15.62	8.22	0.82	1.64	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	30.04	2.97	4.75	1.66	1.07	0.47	0.59	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	20.84	2.28	3.58	0.98	1.30	0.33	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.06	1.20	3.61	1.80	1.60	0.20	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	30.97	1.93	2.20	1.10	1.93	0.28	0.41	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	20.70	2.32	2.32	0.87	2.03	0.00	0.58	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	21.00	1.59	1.70	1.48	1.36	0.00	0.34	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	23.57	2.43	3.02	0.97	1.56	0.19	0.19	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	36.11	3.61	1.20	6.62	1.20	0.60	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	17.23	2.98	7.23	2.77	2.13	0.21	0.00	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	6.86	4.57	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.76	1.86	1.86	1.24	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	16.81	1.37	2.74	2.54	0.78	0.00	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	20.37	6.32	9.83	9.83	2.81	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	27.37	4.62	7.11	3.02	2.84	0.36	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	29.40	4.38	6.57	2.53	2.02	0.51	0.42	0.08	0.25
Pericytes, donor1	11491-119E6	6.56	0.11	1.67	2.34	0.00	0.00	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	7.24	0.45	2.72	1.81	0.23	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	12.82	2.85	5.70	3.87	1.02	0.81	0.81	0.00	0.00
Perineurial Cells, donor1	11499-119F5	28.37	5.20	10.74	8.14	1.81	0.45	0.34	0.00	0.34
Perineurial Cells, donor2	11579-120F4	26.68	9.20	5.43	3.50	2.21	1.29	0.55	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.53	3.82	9.88	6.06	2.23	4.46	0.32	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.20	1.47	4.16	2.20	0.24	0.73	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.25	2.59	10.22	5.18	0.91	1.81	0.39	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	7.65	0.00	1.67	1.67	0.96	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	17.74	4.44	5.54	4.44	1.11	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	16.30	0.20	1.96	1.18	0.79	0.00	0.00	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.87	2.22	0.63	0.63	2.22	0.63	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	16.13	1.88	2.06	3.00	0.75	0.75	0.56	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.84	2.35	4.70	3.00	1.57	0.65	0.65	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	20.49	2.93	3.60	3.38	1.13	0.23	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	22.16	2.88	4.58	3.52	1.81	0.43	0.32	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	24.01	5.24	3.49	3.49	3.49	1.75	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	26.50	5.87	5.16	5.87	2.44	0.72	0.57	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	10.83	2.95	2.95	2.95	0.98	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	14.43	3.07	2.46	1.54	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	33.64	5.84	5.14	3.72	1.42	0.18	0.18	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	24.86	3.92	5.28	2.55	1.70	0.17	0.17	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	30.09	5.22	5.87	2.51	2.14	0.47	0.37	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	21.63	9.20	8.28	7.36	1.84	0.00	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.53	3.03	3.24	3.24	1.25	0.10	0.00	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.20	4.07	4.22	5.58	1.36	0.45	2.56	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	18.82	4.20	2.84	3.79	1.08	0.27	0.41	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	36.31	3.18	2.08	2.20	2.51	0.12	0.24	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	35.08	8.09	9.11	7.97	1.71	0.91	1.03	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	34.25	8.79	7.89	8.25	1.26	2.33	0.72	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	26.17	3.65	3.86	3.55	0.73	0.63	0.10	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	16.42	4.01	4.01	2.55	1.09	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.77	5.82	8.25	6.03	3.12	0.62	1.25	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	16.74	2.03	4.57	4.06	0.51	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.92	0.00	7.82	3.56	1.42	0.00	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	40.76	10.06	9.85	12.81	2.75	0.64	1.16	0.21	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	10.89	7.49	6.81	0.68	1.36	0.68	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.32	9.03	6.20	8.36	2.70	0.81	1.35	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.98	14.21	7.77	8.21	4.66	1.11	1.33	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	2.00	2.00	6.65	0.67	0.67	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.17	3.52	7.48	7.70	0.66	0.66	0.44	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	20.69	3.76	9.40	3.13	0.00	0.63	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	12.76	1.66	3.33	3.05	0.28	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.87	4.56	4.56	4.03	1.07	0.81	1.07	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.51	1.27	1.69	1.69	0.42	0.42	0.84	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.89	4.44	5.98	3.09	1.16	0.00	1.16	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.56	4.93	7.26	3.63	2.85	0.26	0.26	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.90	2.27	7.11	5.68	1.14	0.57	0.85	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	2.06	4.12	3.09	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	27.35	6.27	10.79	6.02	2.01	1.25	2.51	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.88	11.36	5.08	3.88	1.74	0.80	1.07	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	0.89	4.47	0.89	0.89	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	17.06	0.55	8.26	1.10	0.55	0.55	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.14	0.58	10.44	2.32	2.32	0.00	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.27	0.91	5.85	1.43	1.30	0.13	0.91	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.04	1.29	6.65	1.99	1.39	0.00	1.19	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.31	1.56	8.59	2.34	1.67	0.45	0.78	0.11	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.62	1.86	6.70	3.10	2.11	0.50	0.99	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.50	2.21	7.81	2.56	1.98	0.35	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	20.80	1.62	9.48	3.47	3.00	0.00	1.16	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.88	1.10	6.30	1.78	1.51	0.27	1.37	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.51	1.51	5.60	2.12	2.57	0.00	0.30	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	23.83	1.79	7.35	0.90	1.79	0.18	1.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.83	1.00	7.46	2.30	1.72	0.43	1.15	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.89	1.29	7.62	1.40	2.47	0.54	0.75	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	22.57	2.88	5.75	2.66	1.33	0.00	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.85	0.19	6.69	2.49	1.15	0.00	1.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.01	1.02	5.87	1.96	1.30	0.28	1.21	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.99	1.88	8.46	2.44	2.25	0.00	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.50	1.99	5.71	3.45	1.73	0.13	0.80	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.19	2.24	7.20	1.65	1.36	0.29	0.88	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.30	1.72	6.49	1.15	2.10	0.38	1.53	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	21.89	1.50	4.81	3.10	1.39	0.11	1.07	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.27	0.84	7.29	1.96	1.68	0.00	0.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	16.06	0.68	5.30	1.88	1.03	0.68	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.06	0.55	3.65	1.46	2.19	0.00	1.09	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	24.40	0.86	6.25	2.94	1.47	0.37	0.37	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	22.83	0.94	7.12	2.15	0.94	0.00	0.81	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.96	0.47	7.55	5.43	1.42	0.24	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.42	2.58	8.93	1.79	1.59	0.60	0.99	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	20.11	1.64	7.72	1.87	2.10	0.00	1.40	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.13	0.41	6.22	3.11	0.83	0.41	0.62	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.12	0.66	10.18	1.55	1.99	0.66	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.64	2.30	5.64	0.84	1.88	0.21	0.42	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.78	1.08	6.46	3.50	1.62	0.27	0.94	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.95	1.02	6.47	1.36	2.21	0.00	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	24.68	1.35	7.52	1.74	2.12	0.00	1.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	27.17	0.52	7.57	3.95	1.72	0.69	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.93	1.78	7.13	1.78	1.65	0.55	0.55	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	17.24	1.64	7.55	1.64	1.48	0.00	0.49	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.59	1.19	5.11	2.22	1.19	0.00	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.27	2.07	7.25	1.78	2.52	0.44	0.74	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	24.52	1.60	5.60	1.07	1.07	0.00	0.53	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.54	1.38	5.12	2.35	1.66	0.14	1.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.62	0.71	8.81	0.71	1.67	0.48	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.42	1.81	9.47	1.81	1.21	0.20	1.01	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.36	1.41	5.74	1.51	1.13	0.28	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.60	1.40	11.88	0.70	1.40	0.70	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	25.08	2.72	5.44	2.72	1.21	0.30	0.91	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.95	1.35	5.51	2.33	1.22	0.12	0.73	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	33.48	2.62	11.35	1.60	1.46	0.87	1.16	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.69	0.61	5.48	1.83	1.83	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.60	0.90	6.33	2.11	0.90	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	32.57	0.90	8.14	1.13	0.68	0.23	1.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.06	2.10	10.78	1.20	2.10	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.32	1.89	6.02	1.18	1.18	0.47	1.77	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	28.17	2.56	7.26	2.99	0.64	0.43	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	24.64	1.20	9.62	1.20	1.20	1.20	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	10.91	2.26	2.44	0.94	0.56	0.00	0.56	0.00	0.00
Schwann Cells, donor2	11578-120F3	34.02	10.21	6.80	0.00	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	23.00	2.85	2.85	1.97	1.31	0.22	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	22.46	3.29	7.67	3.29	2.74	0.55	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	15.17	0.92	2.76	0.92	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	11.34	3.30	1.86	1.24	0.41	0.00	0.62	0.00	0.21
Sertoli Cells, donor1	11255-116F4	43.07	9.94	1.66	1.66	3.31	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	2.82	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.92	4.40	3.08	1.50	1.41	0.18	1.23	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.00	1.45	2.17	0.72	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.06	5.02	7.52	5.85	0.84	1.67	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.07	3.14	3.30	1.89	1.73	0.16	0.47	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	17.09	0.59	3.57	1.34	0.74	0.00	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	25.24	3.69	3.39	3.54	1.08	0.46	0.92	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.01	4.41	2.52	0.88	3.28	0.00	0.50	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.54	3.28	1.43	2.85	1.43	0.29	0.14	0.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.99	5.75	5.85	2.38	0.99	0.20	0.60	0.10	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	16.43	2.36	3.37	2.36	0.76	0.17	0.59	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	14.48	5.07	5.07	2.17	1.45	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.59	3.16	2.75	2.48	0.69	0.00	0.41	0.00	0.14
Skin - palm, donor1	10286-104F7	21.49	5.37	2.69	5.37	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.96	1.44	3.32	5.48	1.15	0.72	0.72	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	34.35	0.82	13.09	19.63	6.54	6.54	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.11	1.82	1.95	2.34	1.30	0.39	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	27.66	4.17	2.50	2.22	2.50	0.56	0.70	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	33.05	3.94	3.09	1.83	3.38	0.56	0.56	0.28	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	59.63	8.88	7.19	6.98	4.02	0.21	0.42	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	47.29	3.67	1.35	1.42	1.65	0.30	0.82	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	34.56	4.01	6.48	9.57	1.54	1.23	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.34	2.45	5.78	8.89	0.67	0.89	1.33	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	25.86	4.70	3.53	4.70	1.18	1.18	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.67	7.29	4.20	4.20	1.77	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	11.42	8.66	5.91	3.15	0.79	0.39	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	7.73	3.09	5.41	2.32	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	6.00	7.01	8.01	1.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.76	5.86	5.19	4.52	2.53	0.67	0.13	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	28.15	11.75	11.53	14.19	1.11	0.00	0.66	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.90	14.85	9.47	9.86	3.84	1.54	0.38	0.13	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.63	2.60	2.60	1.63	1.95	0.00	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.04	6.79	7.97	5.91	1.48	0.00	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.31	6.98	7.83	7.26	2.14	1.00	0.14	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.16	2.60	4.55	3.09	0.49	0.49	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	2.13	1.22	2.13	2.44	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.41	2.78	3.79	2.02	1.26	0.51	0.51	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	12.24	0.00	6.12	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.74	3.34	3.81	3.34	0.48	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.55	3.83	3.54	4.13	1.62	0.88	0.15	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.54	3.66	3.44	2.58	1.51	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.29	3.57	6.93	2.62	1.68	0.42	0.42	0.00	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	23.51	11.91	8.20	7.89	1.08	0.93	0.46	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	12.93	11.86	3.23	2.16	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.43	5.38	2.09	4.78	2.09	0.60	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	2.05	1.02	3.41	1.71	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.94	3.53	3.46	1.65	3.06	0.31	0.55	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.19	12.48	18.12	29.39	2.31	3.32	1.01	0.20	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	35.50	14.56	6.83	7.96	2.50	1.59	0.46	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	0.60	3.62	4.83	2.42	1.21	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.12	12.19	12.98	10.07	0.79	2.38	0.79	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.08	5.73	6.13	6.13	1.33	1.60	0.80	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	31.30	7.89	6.76	7.64	1.75	1.50	1.00	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	3.55	6.34	4.06	0.76	0.76	1.01	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	27.44	11.46	8.59	7.09	1.81	1.81	0.75	0.15	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	3.00	1.50	0.75	1.50	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	50.40	20.68	3.88	10.34	3.88	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.60	2.33	2.79	3.72	0.47	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	23.22	6.56	8.58	10.60	2.02	3.03	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	27.58	15.04	6.58	10.34	2.19	1.25	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.14	2.95	3.54	0.88	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.91	6.91	3.92	3.42	2.42	0.58	0.58	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.42	3.27	5.14	0.93	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.53	15.97	10.36	12.23	2.73	1.58	1.01	0.29	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.99	23.97	11.47	10.71	1.78	1.02	0.51	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	19.74	17.68	5.45	7.15	1.88	0.75	0.56	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.35	6.29	6.99	3.63	2.66	0.56	0.56	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.64	4.27	5.87	3.85	2.43	0.42	1.34	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	0.95	1.43	2.38	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.56	16.15	7.58	11.50	1.96	2.69	0.73	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.51	4.42	7.07	8.62	1.55	2.65	1.33	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.41	3.22	1.76	0.88	2.34	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.16	3.50	6.80	3.50	1.36	0.78	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.13	3.17	4.76	3.17	1.85	0.53	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.25	1.12	4.09	2.98	1.12	0.74	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.40	2.52	6.11	6.83	2.87	1.44	1.08	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.81	15.05	6.81	19.02	3.41	1.70	0.57	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.60	1.97	5.12	3.15	1.18	1.18	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	1.02	4.57	3.30	0.51	0.76	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	2.00	5.19	2.80	0.80	0.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	20.90	2.51	5.43	2.93	0.42	0.42	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	24.75	2.75	5.96	3.67	1.38	0.92	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	40.90	10.27	25.58	32.99	4.04	1.35	0.84	0.00	0.00
Synoviocyte, donor2	11368-117I9	20.95	2.01	1.84	1.01	0.67	0.00	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	21.89	1.12	2.68	2.01	2.68	0.00	0.45	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	2.14	6.79	5.36	0.36	1.07	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	5.95	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.88	2.32	4.86	1.62	0.46	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	17.35	1.86	2.01	0.86	1.00	0.07	0.29	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	10.44	1.93	1.93	2.32	0.77	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	1.15	1.15	1.15	1.15	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	35.68	11.56	7.01	4.80	2.21	0.74	0.74	0.37	0.00
Urethra, donor2	10319-105A4	26.98	0.00	1.80	0.00	5.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.69	2.92	3.72	1.86	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	10.01	1.60	1.20	0.80	0.00	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.71	0.69	0.46	0.69	0.69	0.23	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	33.88	3.79	3.79	3.12	1.56	0.67	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	3.56	5.34	6.23	2.67	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	1.43	8.58	4.29	0.00	1.43	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	14.37	2.74	4.11	4.11	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.02	2.07	6.54	2.41	0.34	1.03	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.30	1.16	7.55	5.23	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	6.25	3.12	2.08	2.08	0.00	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	9.18	0.92	2.75	4.59	1.84	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	5.48	4.56	0.91	0.00	0.91	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.84	6.78	4.81	7.65	0.62	0.12	0.99	0.12	0.49
Wilms' tumor cell line:HFWT	10597-108E3	17.60	3.52	3.52	2.64	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	32.68	1.96	5.87	1.68	1.12	0.84	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	8.27	4.13	4.13	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	68.84	36.71	31.10	28.05	2.80	2.80	4.59	1.78	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	29.72	2.32	10.68	6.97	0.93	0.00	4.18	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.19	0.71	7.36	1.78	0.00	0.59	0.36	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.17	2.81	5.90	0.84	0.56	0.28	1.69	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	4.41	1.32	4.85	3.53	0.88	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	4.66	12.04	6.21	1.55	0.00	0.78	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.49	0.18	1.10	0.74	0.55	0.00	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3.95	1.16	2.56	0.93	0.23	0.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	1.29	5.95	3.88	0.52	0.26	1.29	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	24.26	1.75	7.01	3.80	1.17	0.00	1.46	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	24.63	3.25	3.25	2.32	1.39	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	10.13	1.23	1.23	0.31	0.31	0.00	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.95	1.28	3.84	0.43	0.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	12.74	0.61	2.43	0.30	0.00	0.00	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.72	0.72	1.93	0.96	0.96	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.00	1.33	0.67	1.00	0.00	1.67	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	29.73	3.72	0.00	0.00	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	1.51	2.26	0.75	0.00	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	9.59	0.87	4.36	0.87	0.87	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	1.87	1.87	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	30.61	3.06	2.35	0.94	1.18	0.00	0.47	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	43.59	15.20	7.29	4.50	3.26	0.31	0.93	0.00	0.16
adipose, donor1	10184-103D4	42.81	7.04	15.25	16.42	4.10	0.59	5.28	0.00	1.76
adipose, donor2	10185-103D5	22.71	6.08	5.68	6.89	2.84	0.00	1.22	0.00	0.00
adipose, donor3	10186-103D6	22.87	3.54	7.90	6.26	1.63	0.54	3.00	0.27	1.09
adipose, donor4	10187-103D7	12.13	1.73	5.20	3.47	0.87	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	135.09	185.60	64.55	96.59	8.52	2.68	9.00	8.84	10.42
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	121.13	73.24	77.64	39.49	4.80	49.23	4.67	1.60	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.72	2.14	3.22	1.43	0.00	0.00	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	28.05	2.09	3.01	2.78	0.00	0.23	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	29.75	1.69	2.70	3.72	1.01	0.34	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	26.51	0.59	2.36	2.06	1.18	0.00	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	8.30	2.37	3.56	2.37	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	22.30	7.71	8.92	10.14	1.42	0.00	0.81	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	10.97	1.61	5.16	9.68	2.26	0.97	0.32	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	37.69	9.55	1.66	1.66	1.91	1.15	0.25	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	41.04	11.25	7.50	2.43	1.32	3.97	0.22	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.37	2.00	2.00	0.33	1.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	42.95	5.88	8.83	3.73	2.75	0.39	0.39	0.00	0.20
appendix, adult	10189-103D9	45.02	8.93	6.99	9.70	1.94	1.55	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	13.41	7.91	3.10	1.38	2.75	0.34	0.69	1.03	0.00
artery, adult	10190-103E1	27.17	4.08	1.36	4.08	5.43	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	56.79	8.84	5.22	4.06	2.61	2.03	0.87	0.00	0.00
b cell line:RPMI1788	10427-106D4	105.58	37.92	30.78	22.01	5.20	3.87	3.42	1.19	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	38.84	15.54	13.87	20.81	4.72	3.05	0.28	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.75	5.16	3.87	2.98	1.09	0.60	0.50	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	24.77	2.34	2.18	1.67	0.17	0.00	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.01	0.56	1.12	0.56	0.56	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	50.41	7.50	4.78	2.39	2.50	0.54	0.43	0.00	0.11
blood, adult, pool1	10053-101G8	6.64	6.64	6.64	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	11.13	9.42	4.28	3.43	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	26.32	10.80	7.42	7.42	0.67	0.00	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	18.45	4.10	4.10	3.08	1.03	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	18.37	6.24	2.45	2.34	0.45	0.11	0.45	0.22	0.11
brain, fetal, pool1	10085-102B4	21.37	2.67	16.03	16.03	2.67	8.01	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	26.43	1.98	1.32	0.00	0.66	0.00	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	19.60	1.25	1.75	0.87	0.87	0.12	0.87	0.00	0.00
breast, adult, donor1	10080-102A8	46.72	16.42	3.16	4.42	3.16	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	27.31	3.30	3.56	1.78	0.64	0.13	0.76	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	7.42	0.00	0.93	0.00	0.31	0.00	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.05	0.23	13.81	8.75	1.15	1.61	0.92	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.60	0.24	1.21	0.48	0.00	0.00	0.48	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	6.11	0.00	1.41	1.88	0.00	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	15.42	12.47	1.64	0.77	0.55	0.11	0.11	1.09	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	6.02	0.00	5.07	3.17	0.00	0.00	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.96	1.60	5.32	1.86	0.53	0.27	0.80	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	19.57	1.15	6.91	4.61	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	20.41	8.20	6.53	5.19	0.50	0.33	0.17	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	13.75	6.88	1.53	6.88	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	16.11	3.66	4.39	10.99	0.73	0.73	2.20	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	26.22	11.65	11.65	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	26.05	7.47	8.75	6.19	1.92	0.64	0.85	0.00	0.21
cerebellum, adult, pool1	10083-102B2	13.80	3.79	0.34	3.10	1.03	0.34	0.34	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	24.91	4.98	4.15	18.27	5.81	2.49	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	23.45	4.03	1.51	3.03	0.50	0.25	1.01	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	8.77	1.46	0.73	1.46	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	44.14	3.74	1.15	1.73	1.01	0.29	0.72	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	42.75	4.47	9.11	4.14	0.83	0.17	0.83	0.00	0.00
cervix, adult, pool1	10013-101C4	38.32	8.29	5.35	2.94	1.57	0.63	0.52	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	26.20	26.75	1.25	1.39	0.84	1.11	0.28	0.84	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	3.92	1.31	2.61	3.92	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.13	2.36	1.49	0.75	0.37	0.12	0.50	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	12.44	1.23	1.60	0.37	0.00	0.00	0.37	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	34.63	3.79	0.71	0.24	1.19	0.00	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	18.52	0.85	0.57	1.42	0.85	0.28	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	44.84	7.26	5.37	3.58	2.39	0.70	1.39	0.00	0.00
chorionic membrane cells, donor3	12240-129G8	21.43	1.65	0.55	0.55	3.30	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1.01	0.00	1.01	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.41	2.88	5.96	1.15	1.15	0.38	0.96	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.68	2.53	1.06	0.00	0.84	0.00	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.86	3.08	2.05	1.03	1.03	0.00	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.03	4.35	1.94	1.45	2.18	0.24	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.30	5.90	3.66	1.63	0.81	0.20	0.81	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	27.68	8.24	2.94	1.47	0.29	0.29	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	22.41	2.09	2.09	0.00	0.78	0.52	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.26	2.97	19.20	8.23	1.14	1.37	0.23	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	20.30	1.74	3.30	5.90	0.69	0.17	0.87	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	20.13	1.46	6.22	8.42	1.28	0.00	2.01	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	98.06	25.09	28.13	14.44	1.14	0.76	5.32	0.00	0.00
colon, adult, donor1	10082-102B1	32.13	2.38	1.19	4.76	0.00	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	36.31	7.52	3.29	1.65	2.23	0.24	0.35	0.59	0.24
colon, fetal, donor1	10070-101I7	34.61	5.56	3.71	4.94	0.62	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	61.19	70.54	39.94	39.09	3.82	6.80	3.82	7.65	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.90	52.07	17.36	19.17	2.11	3.17	2.41	4.08	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	44.14	52.60	17.20	16.64	2.82	2.68	2.68	4.23	1.69
corpus callosum, adult, pool1	10042-101F6	32.06	8.40	8.51	7.41	1.22	0.33	0.44	0.22	0.44
cruciate ligament, donor2	10295-104G7	28.37	3.24	3.24	3.24	2.43	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	26.48	5.62	6.42	3.21	1.61	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	13.68	4.32	2.40	4.08	0.24	0.00	0.72	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	31.23	5.74	13.09	7.35	1.38	1.38	3.21	0.23	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	31.03	2.56	1.80	1.28	1.28	0.00	1.03	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.61	5.06	1.69	0.24	0.00	0.00	0.48	0.00	0.00
ductus deferens, adult	10196-103E7	42.36	7.97	2.99	1.50	1.00	0.00	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	11.52	7.20	2.88	1.44	1.44	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	35.31	11.03	10.30	5.89	3.68	0.00	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	51.62	7.93	7.60	2.15	2.56	0.74	0.41	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.32	6.66	3.78	3.78	0.44	0.89	1.11	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.20	3.87	5.02	5.88	0.43	0.29	0.43	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	45.01	6.17	3.70	1.85	4.32	0.00	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	27.85	2.72	10.90	1.82	1.82	0.61	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	46.00	8.34	3.40	1.85	1.54	0.62	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	59.11	11.82	7.88	1.31	5.25	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.78	9.72	4.02	1.68	0.67	0.00	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	75.76	15.22	31.72	18.67	3.99	3.99	2.36	0.18	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	10.13	1.45	2.57	0.48	0.64	0.16	0.16	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	45.35	4.67	2.33	1.33	0.67	0.11	0.44	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	25.63	3.41	6.27	3.52	1.98	0.55	0.99	0.00	0.11
epididymis, adult	10197-103E8	43.33	5.86	3.56	1.88	0.84	0.42	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.74	3.19	2.31	1.24	0.53	0.00	0.35	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.16	1.18	0.79	0.39	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	37.48	16.25	7.34	5.24	2.10	0.66	0.26	0.79	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.99	18.31	11.42	7.58	2.66	1.08	1.38	0.89	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.10	13.44	7.51	5.04	2.35	0.22	1.46	0.34	0.67
esophagus, adult, pool1	10015-101C6	31.32	4.35	4.14	2.34	1.91	0.42	1.06	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	55.73	36.69	17.78	43.08	18.66	2.63	1.50	2.25	7.76
eye - muscle inferior rectus, donor1	10272-104E2	19.32	7.24	2.41	7.24	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	2.10	0.00	0.00	2.10	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	1.15	1.15	0.00	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	1.46	1.46	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.41	5.85	2.80	2.03	1.02	0.25	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	43.08	10.00	4.49	1.03	1.80	0.51	0.26	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	48.91	12.58	4.75	3.09	1.42	0.00	1.19	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	17.55	4.88	4.13	4.79	0.84	0.47	0.00	0.19	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.13	2.40	7.51	5.10	0.90	0.00	2.10	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.30	4.48	4.85	1.28	1.01	0.27	0.37	0.18	0.00
gall bladder, adult	10198-103E9	42.49	17.14	5.07	4.83	1.45	0.00	0.24	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	4.83	0.00	3.76	1.07	0.00	2.68	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	8.59	0.75	3.73	1.49	0.00	3.36	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.53	4.86	1.69	0.63	1.06	0.63	0.42	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.70	5.22	2.51	0.39	0.39	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	20.17	1.80	9.51	3.77	0.82	0.00	0.82	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	9.15	0.00	21.05	1.83	0.92	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	21.47	59.63	4.57	3.66	6.63	0.00	0.46	7.54	2.74
giant cell carcinoma cell line:LU65	10487-107B1	22.37	3.44	1.61	1.38	1.49	0.11	1.26	0.34	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	42.97	7.00	3.78	0.84	1.26	0.00	0.14	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.16	2.49	5.24	5.74	0.75	0.25	2.74	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.55	3.80	4.86	3.17	2.01	0.11	0.74	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.65	3.51	4.07	2.25	1.26	0.28	0.56	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	30.24	3.86	7.51	2.98	1.21	0.88	0.55	0.00	0.33
glioma cell line:GI-1	10413-106B8	29.29	2.34	2.93	2.64	2.05	0.88	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	15.31	5.83	5.10	4.37	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	30.27	11.47	10.98	8.79	1.46	0.24	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	19.17	4.11	1.37	2.74	1.37	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	2.13	6.93	19.72	1.07	0.53	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	4.89	17.13	2.45	0.00	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	10.93	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.44	4.48	7.04	5.12	1.92	1.28	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	5.51	0.92	0.92	0.46	0.92	0.00	1.38	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.49	0.46	0.91	1.37	0.00	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.09	1.29	1.29	0.00	0.00	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	7.19	0.00	1.44	0.00	0.00	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	0.69	0.00	1.37	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	15.45	4.41	4.41	2.21	0.00	1.10	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	21.55	23.56	32.47	12.36	0.57	2.59	0.86	0.29	0.29
heart - mitral valve, adult	10205-103F7	28.40	7.47	5.98	5.68	1.49	0.30	0.90	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	41.05	7.06	4.97	5.23	1.31	0.00	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	41.63	9.99	9.99	14.15	2.50	1.67	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	24.69	2.24	4.08	1.84	0.82	0.41	0.61	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	25.55	6.39	3.83	2.13	1.28	0.43	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	37.26	8.97	4.14	1.61	1.38	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	49.70	9.86	9.96	8.93	2.77	0.62	0.72	0.10	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.01	4.63	8.33	5.24	3.39	1.54	1.23	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	9.51	1.19	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	37.57	18.01	4.64	4.20	2.65	0.00	0.88	0.55	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	37.02	18.08	5.10	4.01	3.28	0.00	1.46	1.34	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	38.60	17.18	4.14	5.25	3.74	0.00	1.31	0.61	0.00
hepatoma cell line:Li-7	10484-107A7	32.25	12.90	0.33	0.67	0.22	0.00	0.56	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	41.91	39.80	6.43	2.81	1.31	0.40	0.70	2.61	0.60
hippocampus - adult, donor10196	10169-103B7	14.19	8.52	4.73	4.73	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	24.90	10.20	8.37	9.39	1.43	0.00	0.61	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	8.47	1.49	5.48	6.47	1.49	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.93	2.11	7.40	9.16	0.35	1.41	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.87	2.44	3.05	3.66	2.44	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	10.41	3.14	2.95	2.95	0.59	0.20	0.98	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.16	2.29	2.03	2.54	0.25	0.25	1.02	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	36.65	2.82	8.46	9.59	1.69	1.13	5.07	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	45.45	5.42	9.55	11.36	1.29	0.26	5.68	0.00	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	43.66	3.04	6.83	14.05	3.80	0.38	4.18	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	24.82	4.09	9.05	10.22	0.58	1.46	1.75	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.25	3.66	5.82	6.03	0.65	0.65	2.15	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.61	3.34	5.84	5.84	0.83	1.25	1.67	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.91	5.68	6.87	9.00	2.37	0.95	1.66	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	32.46	5.46	5.30	7.23	2.09	0.80	1.93	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	33.67	6.06	7.41	11.45	2.02	0.67	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	9.55	4.23	1.72	3.60	0.94	0.00	0.31	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	1.97	4.42	3.93	0.00	0.49	0.98	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	4.36	2.62	2.62	0.00	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	53.65	6.49	10.88	22.15	1.15	0.95	7.25	0.19	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.22	5.67	11.77	20.50	1.31	0.87	5.67	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	47.98	5.50	12.49	19.99	1.00	1.00	5.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.79	4.71	8.10	7.72	2.64	0.94	2.64	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.28	1.82	8.18	6.37	0.00	0.00	4.09	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.69	4.07	6.58	6.89	1.88	0.00	2.19	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	26.29	4.41	6.53	8.00	2.78	0.82	2.12	0.33	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.00	4.06	5.52	10.45	1.45	0.58	4.35	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.90	3.89	5.98	8.07	1.79	1.20	2.99	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	10.53	1.85	2.59	2.59	0.55	0.37	0.37	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	8.84	1.71	1.14	2.57	0.00	0.00	0.86	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	10.62	3.67	2.86	2.04	1.22	0.41	0.41	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.35	3.52	7.39	17.96	1.41	0.70	3.52	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	32.31	4.43	7.60	12.35	2.22	0.32	2.85	0.00	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.45	3.03	9.99	17.85	1.82	1.21	6.96	0.00	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.89	4.14	3.10	6.72	1.55	0.00	0.00	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	14.61	3.98	3.32	8.63	1.99	0.00	1.33	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.70	4.10	2.82	4.87	1.03	0.51	0.26	0.26	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.20	6.14	5.11	5.11	2.05	0.51	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	3.03	3.79	5.30	3.03	1.51	1.51	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.54	5.38	4.37	5.71	1.68	0.67	1.34	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.76	2.42	0.72	0.72	0.48	0.00	0.48	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.91	1.78	3.12	1.78	0.45	0.45	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.22	1.95	1.95	3.41	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.06	7.95	11.00	21.39	1.83	0.61	5.50	0.31	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	68.32	9.76	19.52	48.80	13.01	0.00	13.01	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.07	5.63	12.24	18.86	1.32	0.33	5.63	0.33	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.31	2.19	12.04	10.40	0.55	0.00	5.47	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.33	3.26	7.24	8.32	0.36	0.36	2.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.62	0.36	8.90	9.61	0.71	0.36	3.56	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	25.06	3.58	3.58	11.93	0.00	1.19	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.15	4.20	7.99	15.17	2.17	1.63	4.74	0.14	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.47	3.23	6.47	9.70	2.42	1.35	3.23	0.27	0.27
immature langerhans cells, donor1	11904-125F5	30.51	2.91	5.33	2.66	2.42	0.97	0.73	0.24	0.24
immature langerhans cells, donor2	11905-125F6	30.89	1.58	2.38	0.79	3.96	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	15.71	7.29	4.54	4.83	0.38	0.47	0.38	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	21.78	0.98	1.63	0.98	0.33	0.00	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	35.04	6.11	3.20	2.60	2.10	0.30	0.50	0.20	0.20
kidney, fetal, pool1	10045-101F9	37.77	6.44	12.17	7.85	2.76	0.78	1.20	0.14	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	55.81	30.25	9.94	8.66	1.56	2.27	0.99	0.99	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.17	0.69	0.28	0.14	0.14	0.14	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.86	10.09	3.67	3.30	2.94	0.55	0.73	0.55	0.18
left atrium, adult, donor1	10079-102A7	21.25	2.72	2.18	0.54	0.54	0.54	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	17.70	2.02	3.03	1.01	1.01	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	7.66	0.82	3.83	0.82	0.27	0.00	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	17.96	6.11	2.51	3.23	2.16	1.08	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	20.65	9.78	3.26	6.52	1.09	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	22.10	7.04	6.07	6.56	2.43	0.73	0.24	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	6.35	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	28.23	4.18	5.23	5.23	3.14	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	21.49	5.19	5.43	1.53	0.59	0.12	0.24	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	22.03	2.81	5.94	3.75	1.41	0.47	0.31	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	27.05	5.60	2.92	2.19	1.58	0.49	0.49	0.49	0.24
liver, adult, pool1	10018-101C9	27.55	18.15	0.97	1.13	0.97	0.16	0.49	0.97	0.32
liver, fetal, pool1	10086-102B5	9.41	10.35	2.82	0.00	0.94	1.88	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.73	5.54	3.06	5.40	1.17	0.00	0.44	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	22.70	5.91	7.75	4.61	0.00	0.55	0.74	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	14.67	5.92	5.92	3.10	2.26	0.28	0.56	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	12.20	2.10	7.15	7.15	2.10	2.94	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	17.85	0.42	1.38	0.14	0.14	0.00	0.28	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	2.76	4.14	2.07	0.00	0.69	0.69	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	35.20	8.62	6.14	3.54	1.42	1.65	0.24	0.12	0.00
lung, fetal, donor1	10068-101I5	49.38	9.13	19.41	15.70	4.57	2.57	2.00	0.29	0.86
lung, right lower lobe, adult, donor1	10075-102A3	31.16	6.87	4.58	5.04	2.29	1.37	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	25.56	8.99	2.84	1.42	2.37	0.95	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.26	13.37	1.97	1.53	0.88	0.88	0.44	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.90	1.06	9.36	5.74	1.81	0.45	2.57	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	42.47	5.10	6.80	0.85	2.55	0.85	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	102.12	18.65	5.33	8.44	4.00	0.00	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	87.58	18.68	4.77	8.09	2.70	0.21	0.42	0.83	0.00
mature adipocyte, donor3	12233-129G1	80.60	14.46	3.79	6.40	3.08	0.00	0.71	0.24	0.47
mature adipocyte, donor4	12234-129G2	105.81	21.32	6.32	10.00	4.74	0.00	1.58	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	35.50	1.91	3.34	1.19	0.71	0.24	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	6.77	2.26	10.15	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	19.31	9.56	8.64	6.62	1.47	0.18	0.55	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	12.07	1.91	2.22	3.49	0.95	0.32	0.32	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	10.24	0.43	9.81	8.53	1.28	0.43	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	13.16	2.53	3.54	4.73	0.68	0.17	0.51	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	22.50	8.91	7.00	10.19	0.21	0.00	0.00	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	3.85	0.00	7.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	28.71	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.64	2.51	10.05	15.43	1.08	1.44	2.51	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	19.47	5.84	3.24	7.14	0.65	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	29.26	6.66	6.97	6.04	1.86	0.15	0.46	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	24.49	8.49	5.47	7.10	0.98	0.08	0.41	0.33	0.33
medulla oblongata, newborn, donor10223	10361-105F1	19.09	5.90	5.55	9.37	1.74	1.39	0.35	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	29.23	2.88	8.64	6.86	1.11	0.00	0.89	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	32.52	14.80	5.87	2.93	0.98	0.37	0.98	0.61	0.37
melanoma cell line:COLO 679	10514-107E1	24.44	5.46	4.17	4.31	2.30	0.14	1.01	0.14	0.00
melanoma cell line:G-361	10465-106H6	31.49	5.70	2.71	0.54	0.00	0.27	1.09	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	21.53	3.26	0.54	0.54	1.81	0.54	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	33.48	6.17	14.98	13.22	0.88	0.00	3.52	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	18.66	2.59	13.48	11.41	1.04	0.00	3.37	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	30.07	4.76	3.68	2.15	1.99	0.00	0.00	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.18	1.64	2.18	2.18	0.73	0.00	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.95	1.66	3.31	3.73	0.41	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.01	1.97	1.97	1.55	1.40	0.00	0.42	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.49	2.31	2.50	1.73	0.96	0.19	0.39	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	4.86	5.55	2.08	2.08	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.09	3.95	3.95	3.78	3.78	0.34	0.69	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.93	2.53	2.99	2.30	1.84	0.12	0.58	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	18.70	2.79	3.71	3.32	1.19	0.53	0.40	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	31.60	5.13	4.86	3.11	1.62	0.41	0.41	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.29	7.82	8.39	7.11	4.69	1.42	0.71	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.08	3.95	3.29	1.98	1.65	0.00	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	25.18	5.12	4.84	3.18	2.63	0.28	0.28	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.23	4.19	4.54	3.84	2.79	0.35	1.05	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.89	4.49	7.76	3.47	2.04	1.22	0.20	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.40	6.83	6.47	4.67	3.95	1.08	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.86	1.45	3.00	2.79	3.10	0.00	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.33	1.37	3.88	2.51	1.37	0.46	0.23	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.24	10.07	7.55	7.97	2.94	0.00	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.24	3.89	5.38	3.74	2.24	0.30	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.64	5.78	3.94	3.33	4.46	0.00	1.14	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.77	2.58	8.47	4.42	2.58	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.47	7.73	7.44	7.73	2.29	2.00	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.58	5.05	8.84	4.63	2.53	0.42	0.00	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.20	1.83	4.11	0.46	1.37	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.18	2.56	2.30	3.33	2.30	0.51	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.79	4.71	3.66	3.14	2.36	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.96	3.39	5.85	1.54	0.92	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.06	2.12	2.35	1.18	1.65	0.24	0.71	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.74	2.71	3.38	2.37	1.35	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.40	4.72	1.18	1.18	1.18	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.27	1.39	1.85	2.78	0.93	1.85	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.67	2.60	4.04	2.88	2.88	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.55	2.90	2.68	2.01	2.01	0.45	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.07	2.88	2.64	2.88	3.12	0.24	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	2.20	1.47	1.47	2.20	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	27.19	1.68	3.36	2.01	1.68	0.00	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.74	2.05	0.82	3.28	1.23	0.00	0.82	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.48	2.58	3.44	2.58	1.72	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	2.73	2.73	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	1.95	2.27	1.62	1.95	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	1.45	0.00	2.91	5.82	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.12	2.67	1.07	2.13	2.67	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	2.45	0.82	1.64	4.09	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.93	2.33	0.39	4.28	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	8.39	4.20	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	0.99	0.00	1.99	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	4.77	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	4.74	3.56	2.37	1.19	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	0.00	0.00	0.00	3.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	28.50	1.27	2.53	0.63	0.00	0.00	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.28	2.07	0.34	0.69	1.72	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	2.15	0.00	0.00	2.15	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	0.00	6.89	0.00	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.08	1.63	1.63	1.22	1.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	3.97	1.59	1.59	2.38	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	1.18	1.77	1.77	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.27	2.18	1.56	1.56	1.87	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	32.08	0.00	2.67	1.34	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	0.00	2.37	5.91	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	2.57	5.14	15.41	0.00	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	4.82	5.51	11.70	1.38	0.00	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	45.52	10.89	10.89	20.78	2.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	14.58	16.82	23.55	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	39.44	10.18	8.27	20.35	3.82	0.64	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	45.13	14.10	7.25	20.15	4.03	0.81	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	17.44	6.54	15.26	2.18	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	8.87	10.14	25.34	5.07	1.27	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	39.45	9.71	5.46	4.25	1.82	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	4.52	13.56	9.04	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	7.41	3.29	9.06	1.65	0.00	0.82	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.72	7.14	9.52	20.44	1.59	0.99	1.19	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.50	9.73	8.76	19.15	2.27	0.97	0.97	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	7.13	9.17	19.35	5.09	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	4.64	4.64	3.09	5.42	0.77	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	62.13	6.38	10.39	3.07	2.36	0.24	2.13	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	48.19	32.20	25.48	35.68	0.70	28.96	0.46	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	30.41	4.93	6.06	7.19	1.54	0.21	0.51	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	55.38	18.38	7.49	14.75	0.68	1.59	0.91	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	44.25	4.16	6.60	2.20	4.16	0.73	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	30.34	3.10	6.42	5.31	3.10	0.66	0.22	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	40.21	8.41	2.63	0.79	0.26	0.00	0.00	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	18.89	4.09	3.92	3.57	0.34	0.17	0.51	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	18.45	3.79	12.13	17.19	1.77	0.00	0.00	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	23.81	1.66	0.62	1.24	1.86	0.21	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	21.87	3.48	3.64	2.48	0.33	0.33	0.50	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	26.42	4.71	2.71	3.44	0.54	0.72	1.09	0.18	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	35.19	5.12	7.69	4.78	3.07	0.51	1.20	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	16.03	1.02	4.07	2.04	1.78	0.51	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	9.79	1.63	2.28	0.65	0.00	0.00	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	23.30	3.52	6.50	3.25	1.63	0.00	0.27	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	29.94	2.11	14.78	7.68	2.88	0.00	1.73	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	26.25	2.56	10.14	3.42	5.74	0.73	1.47	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	36.97	4.67	14.90	6.46	5.20	0.54	0.54	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.65	7.84	3.26	0.98	1.31	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.91	8.90	3.81	0.42	1.27	0.21	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.54	10.37	1.38	0.69	1.61	0.00	0.69	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	49.48	15.41	9.13	7.61	1.71	2.09	0.95	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.24	9.42	7.76	4.07	1.85	0.18	0.92	0.00	0.55
myeloma cell line:PCM6	10474-106I6	29.06	4.15	0.79	0.40	0.79	0.00	0.20	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.23	2.03	5.07	3.04	1.01	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.58	5.88	3.33	3.33	0.78	2.16	0.59	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.20	1.34	1.56	0.67	0.67	0.22	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.84	1.69	1.40	1.62	1.10	0.07	0.22	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	32.57	2.76	1.66	1.10	0.55	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	38.42	5.98	15.18	7.82	0.46	0.92	2.30	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	34.05	8.42	9.17	4.68	1.31	0.00	0.94	0.56	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	21.93	2.11	4.22	2.74	0.21	0.21	0.63	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	27.58	4.29	3.91	2.24	0.56	0.19	1.30	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.16	1.19	20.16	6.88	0.47	0.24	1.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.75	2.06	9.82	3.48	0.63	0.32	0.79	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	18.31	2.01	7.04	1.61	0.40	0.40	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	0.64	8.90	3.18	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	27.95	5.59	5.86	4.26	2.13	0.27	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.32	6.09	14.54	6.09	1.86	0.34	2.37	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.02	14.41	2.40	4.00	0.80	0.00	0.00	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.37	3.21	4.49	2.56	1.28	0.96	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.74	4.20	8.15	3.42	1.05	0.79	0.79	0.00	0.53
nucleus accumbens, adult, pool1	10037-101F1	18.28	5.62	5.06	4.69	0.94	0.56	0.47	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	8.24	2.06	2.06	8.24	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	25.49	8.32	5.90	9.93	1.61	0.00	0.81	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	10.92	2.91	5.46	9.83	1.46	0.36	1.46	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	20.73	3.94	2.36	2.36	0.52	0.00	0.26	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	50.20	3.00	51.06	27.46	2.15	8.15	6.87	0.00	0.43
occipital pole, adult, pool1	10036-101E9	12.93	4.73	2.92	2.84	0.32	0.16	0.47	0.08	0.00
olfactory region, adult	10195-103E6	12.23	3.82	2.48	4.39	1.15	0.19	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	26.01	4.00	2.00	6.00	6.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.31	2.51	1.82	3.08	2.05	0.23	1.37	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.84	1.10	6.73	2.47	0.69	0.14	0.69	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.90	0.68	2.20	1.69	0.85	0.00	0.51	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.33	2.66	0.92	1.16	0.92	0.00	0.23	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	27.63	2.06	2.65	1.18	1.47	0.29	0.00	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	34.57	18.69	5.61	1.87	1.87	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.30	1.91	4.67	2.12	0.85	0.00	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	42.02	8.04	5.33	4.02	1.66	0.44	0.96	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.53	1.10	0.55	0.18	0.37	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	26.34	11.29	1.88	0.00	0.94	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.41	1.12	0.56	0.56	0.28	0.00	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	40.37	11.41	4.94	5.11	2.56	0.85	0.51	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	59.78	7.12	6.95	3.15	2.65	0.17	1.49	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	16.11	5.58	4.76	4.12	0.82	0.18	0.37	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	8.07	2.20	0.73	4.40	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	5.64	1.88	8.46	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	16.82	6.84	7.13	7.41	0.57	0.29	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	16.57	4.85	5.29	4.32	1.23	0.00	0.26	0.35	0.00
parietal lobe, fetal, donor1	10072-101I9	47.52	3.88	46.55	25.22	0.97	3.88	6.79	0.97	2.91
parietal lobe, newborn, donor10223	10356-105E5	11.59	1.12	9.35	14.21	2.24	1.50	1.12	0.00	0.37
parotid gland, adult	10199-103F1	26.52	3.70	2.47	3.70	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	31.15	8.59	7.52	3.76	0.54	0.00	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	13.76	0.93	5.02	0.74	0.37	0.00	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.29	3.35	4.23	3.06	1.17	0.44	0.87	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	10.32	1.94	0.65	0.65	0.00	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	30.80	7.11	4.15	4.74	0.59	1.18	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	17.56	3.14	1.25	1.25	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	47.55	9.11	3.04	5.06	1.01	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	46.38	9.90	7.30	3.65	2.61	0.00	1.56	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	26.39	4.26	0.00	0.85	2.55	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	28.27	3.98	4.52	2.90	1.08	0.54	0.22	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	40.79	13.64	14.17	8.34	1.72	1.72	1.46	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.63	7.32	7.94	4.67	3.42	1.25	1.40	0.16	0.31
pons, adult, pool1	10033-101E6	20.66	8.00	3.96	4.13	1.81	0.34	0.52	0.17	0.00
postcentral gyrus, adult, pool1	10032-101E5	15.34	5.06	3.40	3.14	0.61	0.26	0.26	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	19.23	0.44	6.55	2.18	1.02	0.00	0.58	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	48.46	33.94	12.16	8.17	1.45	2.90	0.73	1.09	0.73
prostate, adult, pool1	10022-101D4	35.01	6.26	4.90	2.27	2.00	0.54	0.54	0.18	0.00
putamen, adult, donor10196	10176-103C5	15.11	7.32	5.67	3.78	0.94	0.24	0.24	0.24	0.24
putamen, adult, donor10252	10152-102I8	17.65	5.88	7.84	5.88	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	3.28	2.19	2.19	3.28	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.94	3.62	3.38	4.59	0.48	0.24	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	16.49	2.25	11.24	17.24	3.00	0.75	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	32.29	3.78	0.87	1.45	1.16	0.29	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	31.99	2.78	5.56	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.98	2.76	10.18	4.45	2.97	1.27	1.06	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.17	1.24	3.31	0.41	0.83	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	36.28	5.86	5.07	2.39	0.70	0.10	0.50	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	39.49	7.79	15.85	6.75	1.04	0.52	1.82	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	46.23	44.63	10.33	20.53	5.90	2.21	1.35	1.97	3.93
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	37.68	4.50	18.00	3.37	0.84	0.56	0.56	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.17	3.79	3.79	5.30	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	20.56	3.08	1.78	1.13	1.46	0.00	0.81	0.16	0.16
salivary acinar cells, donor2	11772-123I8	20.24	1.79	2.48	0.14	1.24	0.00	0.00	0.00	0.00
salivary acinar cells, donor3	11773-123I9	29.13	3.97	2.65	2.65	1.32	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	18.30	4.00	3.43	1.72	1.14	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.00	3.20	2.19	1.26	1.01	0.93	0.34	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	35.62	4.94	1.65	0.59	1.18	0.82	0.00	0.00	0.24
seminal vesicle, adult	10201-103F3	34.92	4.76	3.17	0.53	1.06	0.00	0.53	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	40.33	5.34	9.23	12.88	3.16	0.73	1.21	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.92	2.77	3.27	5.28	2.01	0.00	1.01	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	4.01	7.02	4.01	1.00	0.00	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.72	0.54	0.67	0.27	0.00	0.00	0.00	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	23.21	7.29	0.66	0.44	0.44	0.11	0.22	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.87	12.77	4.90	3.87	2.32	0.26	0.52	0.77	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	2.13	0.00	0.00	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	29.74	8.88	3.00	1.56	1.44	0.12	0.24	0.36	0.60
skeletal muscle, fetal, donor1	10066-101I3	19.10	2.01	3.02	1.01	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.19	11.36	6.31	3.79	1.26	0.00	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.34	2.00	2.00	2.33	0.00	0.33	0.67	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.27	14.50	9.14	6.93	1.89	0.32	0.32	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	28.53	0.96	6.94	2.51	1.93	0.00	0.77	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	59.17	6.10	3.96	2.80	2.47	0.16	2.97	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	46.97	8.04	10.46	4.66	0.64	0.48	1.61	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	35.30	13.29	1.31	0.22	0.22	0.00	0.00	0.44	0.00
small intestine, adult, pool1	10024-101D6	40.01	5.97	2.99	1.55	4.06	0.24	0.60	0.36	0.24
small intestine, fetal, donor1	10064-101I1	27.52	1.72	4.91	3.19	1.97	0.25	0.49	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.87	56.42	1.54	1.54	6.15	1.03	0.00	9.75	3.08
smooth muscle, adult, pool1	10048-101G3	59.96	6.20	4.91	2.84	2.58	0.52	0.78	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	21.17	33.77	1.07	0.27	1.88	0.27	0.54	2.95	1.34
spinal cord - adult, donor10196	10181-103D1	16.98	6.19	2.98	4.36	0.69	0.46	1.15	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	29.18	7.89	3.55	6.70	1.18	0.79	1.58	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	13.14	2.08	6.92	6.23	2.08	0.69	0.69	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	34.15	7.32	6.71	7.93	1.83	0.61	0.00	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	21.58	2.30	7.35	8.27	4.59	0.46	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.23	10.45	6.12	5.23	1.79	0.60	0.30	0.15	0.30
spleen, adult, pool1	10025-101D7	38.22	19.49	6.17	6.17	2.53	1.10	0.88	0.99	0.22
spleen, fetal, pool1	10044-101F8	33.21	20.58	15.26	10.41	1.83	1.27	2.07	0.48	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	53.00	10.56	10.35	5.59	1.55	0.41	1.14	0.21	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.65	0.95	4.94	1.33	0.38	0.00	0.19	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	21.32	1.75	4.54	5.24	0.35	0.70	0.35	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	7.43	1.95	1.17	0.78	0.39	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.14	3.83	0.79	0.45	1.24	0.34	0.34	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	35.58	1.27	4.24	6.35	0.85	0.00	0.85	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.92	5.50	5.92	5.92	2.96	0.00	1.27	0.85	0.00
stomach, fetal, donor1	10062-101H8	64.08	10.68	2.14	3.20	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	30.76	5.13	2.85	4.56	1.14	1.14	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	30.12	5.82	6.44	4.78	1.66	0.21	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	9.31	3.10	5.17	4.66	0.52	0.00	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.25	3.53	8.48	16.96	2.83	2.12	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.42	1.38	2.98	1.38	0.46	0.00	0.69	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	15.26	3.81	3.39	3.22	0.51	0.42	0.34	0.25	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.02	4.27	34.90	12.82	0.00	1.42	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.48	2.20	29.45	21.54	1.32	4.83	2.20	0.44	0.88
tenocyte, donor1	11763-123H8	23.74	2.44	3.84	2.79	1.75	0.00	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	17.93	1.14	2.29	1.91	1.53	0.76	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	17.42	1.48	8.90	2.97	1.48	0.37	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	51.67	13.09	1.70	3.23	2.38	0.34	1.02	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	15.72	3.39	5.70	2.77	0.77	0.31	0.77	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	36.42	7.28	1.24	1.55	1.39	0.00	1.39	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	14.73	5.08	1.27	2.54	0.25	0.00	0.13	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.80	3.78	0.76	1.13	0.38	0.00	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	20.50	8.72	0.65	0.44	0.87	0.00	0.22	0.65	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	13.68	4.56	1.63	2.28	1.30	0.00	0.65	0.00	0.33
testis, adult, pool1	10026-101D8	57.23	6.98	5.15	2.47	2.25	0.54	0.43	0.11	0.43
testis, adult, pool2	10096-102C6	44.21	4.06	5.41	4.96	1.80	0.00	1.35	0.00	0.00
thalamus - adult, donor10196	10168-103B6	16.56	5.52	2.21	3.31	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	24.54	8.60	6.25	6.72	0.78	0.00	0.00	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	6.16	9.24	13.86	0.00	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.49	2.31	2.14	4.78	0.66	0.16	0.49	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	6.33	2.30	3.45	2.88	1.15	1.73	1.15	0.00	0.00
throat, adult	10209-103G2	30.46	4.49	2.75	4.24	1.00	0.00	0.75	0.00	0.00
throat, fetal, donor1	10061-101H7	35.35	4.27	5.48	3.96	0.00	0.61	1.22	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	16.49	0.99	1.59	0.79	0.79	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	13.52	1.79	10.34	3.18	0.40	0.60	1.39	0.00	0.00
thymus, fetal, pool1	10043-101F7	17.04	3.43	10.49	6.55	0.52	0.52	1.66	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.11	2.93	1.99	1.06	1.73	0.13	0.27	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	50.29	7.26	1.54	0.84	0.42	0.28	0.00	0.00	0.14
thyroid, adult, pool1	10028-101E1	43.58	7.74	3.17	2.24	1.40	0.28	0.65	0.09	0.19
thyroid, fetal, donor1	10060-101H6	65.12	10.55	9.76	3.95	2.64	0.26	0.79	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	23.96	3.49	1.63	1.16	0.70	0.00	0.00	0.00	0.23
tongue, fetal, donor1	10059-101H5	22.07	5.52	1.58	3.15	1.18	0.39	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	33.26	9.52	12.32	7.91	0.80	1.30	1.50	0.40	0.10
trachea, adult, pool1	10029-101E2	25.36	5.24	2.70	2.54	0.90	0.25	0.16	0.33	0.08
trachea, fetal, donor1	10058-101H4	28.85	3.85	4.62	2.31	2.31	0.38	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	39.32	10.98	7.44	6.02	2.48	0.71	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	17.73	4.36	5.07	1.82	0.91	0.30	1.01	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	58.91	7.05	4.07	1.10	1.88	0.31	0.78	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	20.93	3.81	0.00	0.00	11.42	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	23.36	4.99	2.12	0.42	0.76	0.00	0.00	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	25.04	4.17	6.26	6.26	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	39.07	7.17	10.75	8.53	3.07	0.85	1.19	0.00	0.00
uterus, fetal, donor1	10055-101H1	47.61	5.63	6.14	4.10	1.54	0.51	0.51	0.00	0.51
vagina, adult	10204-103F6	31.66	10.34	1.29	3.23	3.88	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	28.93	11.18	9.43	7.01	2.19	0.66	1.32	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	19.49	2.40	9.88	3.47	0.80	0.27	0.00	0.00	0.00